0001015383 false --03-31 Q2 0001015383
2022-04-01 2022-09-30 0001015383
POWW:CommonStock0.001ParValueMember 2022-04-01 2022-09-30
0001015383
POWW:Sec8.75SeriesCumulativeRedeemablePerpetualPreferredStock0.001ParValueMember
2022-04-01 2022-09-30 0001015383 2022-11-11 0001015383 2022-09-30
0001015383 2022-03-31 0001015383 2021-04-01 2022-03-31 0001015383
2022-07-01 2022-09-30 0001015383 2021-07-01 2021-09-30 0001015383
2021-04-01 2021-09-30 0001015383 POWW:AmmunitionSalesMember
2022-07-01 2022-09-30 0001015383 POWW:AmmunitionSalesMember
2021-07-01 2021-09-30 0001015383 POWW:AmmunitionSalesMember
2022-04-01 2022-09-30 0001015383 POWW:AmmunitionSalesMember
2021-04-01 2021-09-30 0001015383 POWW:MarketplaceRevenueMember
2022-07-01 2022-09-30 0001015383 POWW:MarketplaceRevenueMember
2021-07-01 2021-09-30 0001015383 POWW:MarketplaceRevenueMember
2022-04-01 2022-09-30 0001015383 POWW:MarketplaceRevenueMember
2021-04-01 2021-09-30 0001015383 POWW:CasingSalesMember 2022-07-01
2022-09-30 0001015383 POWW:CasingSalesMember 2021-07-01 2021-09-30
0001015383 POWW:CasingSalesMember 2022-04-01 2022-09-30 0001015383
POWW:CasingSalesMember 2021-04-01 2021-09-30 0001015383
us-gaap:PreferredStockMember 2022-03-31 0001015383
us-gaap:CommonStockMember 2022-03-31 0001015383
us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001015383
us-gaap:RetainedEarningsMember 2022-03-31 0001015383
us-gaap:PreferredStockMember 2022-06-30 0001015383
us-gaap:CommonStockMember 2022-06-30 0001015383
us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001015383
us-gaap:RetainedEarningsMember 2022-06-30 0001015383 2022-06-30
0001015383 us-gaap:PreferredStockMember 2021-03-31 0001015383
us-gaap:CommonStockMember 2021-03-31 0001015383
us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001015383
us-gaap:RetainedEarningsMember 2021-03-31 0001015383 2021-03-31
0001015383 us-gaap:PreferredStockMember 2021-06-30 0001015383
us-gaap:CommonStockMember 2021-06-30 0001015383
us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001015383
us-gaap:RetainedEarningsMember 2021-06-30 0001015383 2021-06-30
0001015383 us-gaap:PreferredStockMember 2022-04-01 2022-06-30
0001015383 us-gaap:CommonStockMember 2022-04-01 2022-06-30
0001015383 us-gaap:AdditionalPaidInCapitalMember 2022-04-01
2022-06-30 0001015383 us-gaap:RetainedEarningsMember 2022-04-01
2022-06-30 0001015383 2022-04-01 2022-06-30 0001015383
us-gaap:PreferredStockMember 2022-07-01 2022-09-30 0001015383
us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001015383
us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30
0001015383 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30
0001015383 us-gaap:PreferredStockMember 2021-04-01 2021-06-30
0001015383 us-gaap:CommonStockMember 2021-04-01 2021-06-30
0001015383 us-gaap:AdditionalPaidInCapitalMember 2021-04-01
2021-06-30 0001015383 us-gaap:RetainedEarningsMember 2021-04-01
2021-06-30 0001015383 2021-04-01 2021-06-30 0001015383
us-gaap:PreferredStockMember 2021-07-01 2021-09-30 0001015383
us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001015383
us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30
0001015383 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30
0001015383 us-gaap:PreferredStockMember 2022-09-30 0001015383
us-gaap:CommonStockMember 2022-09-30 0001015383
us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001015383
us-gaap:RetainedEarningsMember 2022-09-30 0001015383
us-gaap:PreferredStockMember 2021-09-30 0001015383
us-gaap:CommonStockMember 2021-09-30 0001015383
us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001015383
us-gaap:RetainedEarningsMember 2021-09-30 0001015383 2021-09-30
0001015383 us-gaap:PatentsMember
POWW:ExclusiveLicenseAgreementMember 2022-09-30 0001015383
us-gaap:PatentsMember POWW:ExclusiveLicenseAgreementMember
2022-04-01 2022-09-30 0001015383 us-gaap:PatentsMember
POWW:ExclusiveLicenseAgreementMember 2021-04-01 2021-09-30
0001015383 us-gaap:SellingAndMarketingExpenseMember 2022-04-01
2022-09-30 0001015383 us-gaap:SellingAndMarketingExpenseMember
2021-04-01 2021-09-30 0001015383 us-gaap:CostOfSalesMember
2022-04-01 2022-09-30 0001015383 us-gaap:CostOfSalesMember
2021-04-01 2021-09-30 0001015383
POWW:EmployeesBoardOfDirectorsAndAdvisoryCommitteeMembersMember
2022-07-01 2022-09-30 0001015383
POWW:EmployeesBoardOfDirectorsAndAdvisoryCommitteeMembersMember
2022-04-01 2022-09-30 0001015383 srt:MaximumMember 2022-09-30
0001015383 us-gaap:CustomerConcentrationRiskMember
us-gaap:SalesRevenueNetMember POWW:CustomerAMember 2022-07-01
2022-09-30 0001015383 us-gaap:CustomerConcentrationRiskMember
us-gaap:SalesRevenueNetMember POWW:CustomerAMember 2022-04-01
2022-09-30 0001015383 us-gaap:CustomerConcentrationRiskMember
us-gaap:AccountsReceivableMember POWW:CustomerAMember 2022-07-01
2022-09-30 0001015383 us-gaap:CustomerConcentrationRiskMember
us-gaap:AccountsReceivableMember POWW:CustomerAMember 2022-04-01
2022-09-30 0001015383 us-gaap:CustomerConcentrationRiskMember
us-gaap:SalesRevenueNetMember POWW:CustomerMember 2022-07-01
2022-09-30 0001015383 us-gaap:CustomerConcentrationRiskMember
us-gaap:SalesRevenueNetMember POWW:CustomerMember 2022-04-01
2022-09-30 0001015383 us-gaap:CustomerConcentrationRiskMember
us-gaap:AccountsReceivableMember POWW:CustomerMember 2022-07-01
2022-09-30 0001015383 us-gaap:CustomerConcentrationRiskMember
us-gaap:AccountsReceivableMember POWW:CustomerMember 2022-04-01
2022-09-30 0001015383 POWW:MarketplaceFeeRevenueMember 2022-07-01
2022-09-30 0001015383 POWW:MarketplaceFeeRevenueMember 2021-07-01
2021-09-30 0001015383 POWW:MarketplaceFeeRevenueMember 2022-04-01
2022-09-30 0001015383 POWW:MarketplaceFeeRevenueMember 2021-04-01
2021-09-30 0001015383 POWW:AmmunitionCasingsSalesMember 2022-07-01
2022-09-30 0001015383 POWW:AmmunitionCasingsSalesMember 2021-07-01
2021-09-30 0001015383 POWW:AmmunitionCasingsSalesMember 2022-04-01
2022-09-30 0001015383 POWW:AmmunitionCasingsSalesMember 2021-04-01
2021-09-30 0001015383 us-gaap:WarrantMember 2022-09-30 0001015383
POWW:CommonStockWarrantMember 2022-07-01 2022-09-30 0001015383
POWW:EquityIncentiveAwardMember 2022-07-01 2022-09-30 0001015383
us-gaap:WarrantMember 2022-04-01 2022-09-30 0001015383
us-gaap:BuildingMember 2022-09-30 0001015383 us-gaap:BuildingMember
2022-03-31 0001015383 us-gaap:ConstructionInProgressMember
2022-09-30 0001015383 us-gaap:ConstructionInProgressMember
2022-03-31 0001015383 us-gaap:LeaseholdImprovementsMember
2022-09-30 0001015383 us-gaap:LeaseholdImprovementsMember
2022-03-31 0001015383 us-gaap:FurnitureAndFixturesMember 2022-09-30
0001015383 us-gaap:FurnitureAndFixturesMember 2022-03-31 0001015383
us-gaap:VehiclesMember 2022-09-30 0001015383 us-gaap:VehiclesMember
2022-03-31 0001015383 us-gaap:EquipmentMember 2022-09-30 0001015383
us-gaap:EquipmentMember 2022-03-31 0001015383
us-gaap:ToolsDiesAndMoldsMember 2022-09-30 0001015383
us-gaap:ToolsDiesAndMoldsMember 2022-03-31 0001015383
POWW:FactoringAndSecurityAgreementMember 2019-07-01 0001015383
POWW:FactoringAndSecurityAgreementMember 2019-06-28 2019-07-01
0001015383 POWW:FactoringAndSecurityAgreementMember
us-gaap:PrimeRateMember 2019-06-28 2019-07-01 0001015383 2021-06-16
2021-06-17 0001015383
POWW:RevolvingInventoryLoanAndSecurityAgreementMember
POWW:EligibleInventoryMember 2020-06-17 0001015383
POWW:RevolvingInventoryLoanAndSecurityAgreementMember 2020-06-15
2020-06-17 0001015383
POWW:RevolvingInventoryLoanAndSecurityAgreementMember 2020-06-17
0001015383 POWW:RevolvingInventoryLoanAndSecurityAgreementMember
2020-07-31 0001015383 2021-09-01 2021-09-30 0001015383 2022-01-01
2022-01-31 0001015383 POWW:ConstructionLoanAgreementMember
POWW:HiawathaNationalBankMember srt:MaximumMember 2021-10-14
0001015383 POWW:ConstructionLoanAgreementMember
POWW:HiawathaNationalBankMember 2021-10-14 0001015383
POWW:ConstructionLoanAgreementMember
POWW:HiawathaNationalBankMember POWW:FirstAdvanceMember 2021-10-13
2021-10-14 0001015383 POWW:PromissoryNoteMember
POWW:HiawathaNationalBankMember srt:MaximumMember 2021-10-14
0001015383 POWW:PromissoryNoteMember
POWW:HiawathaNationalBankMember 2021-10-14 0001015383
POWW:PromissoryNoteMember POWW:HiawathaNationalBankMember
2021-10-13 2021-10-14 0001015383
POWW:ConstructionLoanAgreementMember
POWW:HiawathaNationalBankMember 2021-10-13 2021-10-14 0001015383
POWW:ConstructionLoanAgreementMember
POWW:HiawathaNationalBankMember 2022-04-01 2022-09-30 0001015383
POWW:ConstructionLoanAgreementMember
POWW:HiawathaNationalBankMember 2022-09-30 0001015383
POWW:NewIssuanceOfSharesMember 2022-04-01 2022-09-30 0001015383
us-gaap:CommonStockMember 2022-04-01 2022-09-30 0001015383
POWW:EmployeesMembersBoardOfDirectorsMember 2022-04-01 2022-09-30
0001015383 us-gaap:WarrantMember 2022-09-30 0001015383
us-gaap:WarrantMember 2022-04-01 2022-09-30 0001015383
POWW:WarrantOneMember POWW:UntilAprilTwoThousandTwentyFiveMember
2022-09-30 0001015383 POWW:WarrantTwoMember
POWW:UntilAugustTwoThousandTwentyFourMember 2022-09-30 0001015383
POWW:WarrantThreeMember
POWW:UntilSeptemberTwoThousandTwentyFourMember 2022-09-30
0001015383 POWW:WarrantFourMember
POWW:UntilNovemberTwoThousandTwentyFiveMember 2022-09-30 0001015383
POWW:WarrantFiveMember
POWW:UntilFebrauryTwoThousandTwentyFourMember 2022-09-30 0001015383
us-gaap:WarrantMember 2022-03-31 0001015383
us-gaap:SeriesAPreferredStockMember 2021-05-18 0001015383
us-gaap:SeriesAPreferredStockMember 2021-05-18 2021-05-18
0001015383 us-gaap:SeriesAPreferredStockMember 2022-04-01
2022-09-30 0001015383 us-gaap:SeriesAPreferredStockMember
2021-08-30 2021-08-31 0001015383
us-gaap:SeriesAPreferredStockMember 2021-09-15 2021-09-15
0001015383 us-gaap:SeriesAPreferredStockMember 2022-05-28
2022-05-31 0001015383 us-gaap:SeriesAPreferredStockMember
2022-06-15 2022-06-15 0001015383 POWW:MergerAgreementMember
POWW:GeminiDirectInvestmentsLLCMember 2021-04-30 0001015383
POWW:MergerAgreementMember POWW:GeminiDirectInvestmentsLLCMember
2021-04-29 2021-04-30 0001015383
POWW:WithoutBeingHeldInEscrowOrRequiringPriorStockholderApprovalMember
2021-04-29 2021-04-30 0001015383
POWW:PledgeAndEscrowAgreementMember 2021-04-29 2021-04-30
0001015383 POWW:WillNotBeIssuedPriorToTheStockholderApprovalMember
2021-04-29 2021-04-30 0001015383
POWW:GeminiDirectInvestmentsLLCMember 2021-04-29 2021-04-30
0001015383 POWW:GeminiDirectInvestmentsLLCMember 2021-04-30
0001015383 2021-04-29 2021-04-30 0001015383 2021-04-01 2021-04-02
0001015383 2022-04-30 0001015383 POWW:JesseJamesMember 2022-04-01
2022-09-30 0001015383 us-gaap:LicensingAgreementsMember
POWW:JesseJamesMember 2022-09-30 0001015383 POWW:JeffRannMember
2022-04-01 2022-09-30 0001015383 us-gaap:LicensingAgreementsMember
POWW:JeffRannMember 2022-09-30 0001015383
POWW:StreakVisualAmmunitionPatentMember 2022-04-01 2022-09-30
0001015383 POWW:StreakVisualAmmunitionPatentMember 2022-09-30
0001015383 POWW:SWKPatentAcquisitionMember 2022-04-01 2022-09-30
0001015383 POWW:SWKPatentAcquisitionMember 2022-09-30 0001015383
us-gaap:CustomerRelationshipsMember 2022-04-01 2022-09-30
0001015383 us-gaap:CustomerRelationshipsMember 2022-09-30
0001015383 us-gaap:IntellectualPropertyMember 2022-04-01 2022-09-30
0001015383 us-gaap:IntellectualPropertyMember 2022-09-30 0001015383
POWW:TradenameMember 2022-04-01 2022-09-30 0001015383
POWW:TradenameMember 2022-09-30 0001015383 POWW:TradenameMember
POWW:GDIAcquisitionMember 2022-04-01 2022-09-30 0001015383
POWW:GDIAcquisitionMember POWW:TradenameMember 2022-09-30
0001015383 us-gaap:CustomerListsMember POWW:GDIAcquisitionMember
2022-04-01 2022-09-30 0001015383 us-gaap:CustomerListsMember
POWW:GDIAcquisitionMember 2022-09-30 0001015383
us-gaap:IntellectualPropertyMember POWW:GDIAcquisitionMember
2022-04-01 2022-09-30 0001015383 POWW:GDIAcquisitionMember
us-gaap:IntellectualPropertyMember 2022-09-30 0001015383
us-gaap:OtherIntangibleAssetsMember POWW:GDIAcquisitionMember
2022-04-01 2022-09-30 0001015383 POWW:GDIAcquisitionMember
us-gaap:OtherIntangibleAssetsMember 2022-09-30 0001015383
us-gaap:LicensingAgreementsMember 2022-09-30 0001015383
us-gaap:PatentsMember 2022-09-30 0001015383
us-gaap:OtherIntangibleAssetsMember 2022-09-30 0001015383
POWW:AmmunitionMember 2022-07-01 2022-09-30 0001015383
POWW:MarketplaceMember 2022-07-01 2022-09-30 0001015383
POWW:CorporateAndOtherExpensesMember 2022-07-01 2022-09-30
0001015383 POWW:AmmunitionMember 2022-04-01 2022-09-30 0001015383
POWW:MarketplaceMember 2022-04-01 2022-09-30 0001015383
POWW:CorporateAndOtherExpensesMember 2022-04-01 2022-09-30
0001015383 POWW:AmmunitionMember 2021-07-01 2021-09-30 0001015383
POWW:MarketplaceMember 2021-07-01 2021-09-30 0001015383
POWW:CorporateAndOtherExpensesMember 2021-07-01 2021-09-30
0001015383 POWW:AmmunitionMember 2021-04-01 2021-09-30 0001015383
POWW:MarketplaceMember 2021-04-01 2021-09-30 0001015383
POWW:CorporateAndOtherExpensesMember 2021-04-01 2021-09-30
0001015383 POWW:BoardOfDirectorsMember 2022-09-30 0001015383
POWW:MarketplaceRevenueMember POWW:BoardOfDirectorsMember
2022-04-01 2022-09-30 0001015383 POWW:EmployeesMember
us-gaap:SubsequentEventMember 2022-11-13 2022-11-14 0001015383
POWW:EmployeesMember us-gaap:SubsequentEventMember 2022-11-14
0001015383 us-gaap:SubsequentEventMember us-gaap:WarrantMember
2022-11-13 2022-11-14 iso4217:USD xbrli:shares iso4217:USD
xbrli:shares xbrli:pure utr:sqft
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C.
FORM
10-Q
☒ |
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934 |
|
|
For
the quarterly period ended
September 30,
2022 |
|
OR |
|
|
☐ |
TRANSITION
REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934 |
|
|
For
the transition period from ________ to ________ |
AMMO, Inc.
(Exact
Name of Registrant as Specified in its Charter)
delaware |
|
001-13101 |
|
83-1950534 |
(State
of
incorporation)
|
|
(Commission
File
No.)
|
|
(I.R.S.
Identification
Number)
|
7681 E Gray Road,
Scottsdale,
AZ
85260
(Address
of Principal Executive Offices) (Zip Code)
Registrant’s
telephone number including area code:
(480)
947-0001
Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
Common Stock, $0.001 par value |
|
POWW |
|
The
Nasdaq Stock Market LLC (Nasdaq
Capital
Market)
|
8.75% Series A Cumulative Redeemable Perpetual Preferred Stock,
$0.001 par value |
|
POWWP |
|
The
Nasdaq Stock Market LLC (Nasdaq
Capital
Market)
|
Indicate
by check mark whether the issuer (1) filed all reports required to
be filed by Sections 13 or 15(d) of the Securities Exchange Act of
1934 during the past 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days.
Yes ☒ No ☐
Indicate
by check mark whether the registrant has submitted electronically
every Interactive Data File required to be submitted pursuant to
rule 405 of Regulation S-T (§232.405 of this chapter) during the
preceding 12 months (or for such shorter period that the registrant
was required to submit such files).
Yes ☒ No ☐
Indicate
by check mark whether the registrant is a large accelerated filer,
an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of
“large accelerated filer,” “accelerated filer,” “smaller reporting
company,” and “emerging growth company” in Rule 12b-2 of the
Exchange Act.
Large
accelerated filer ☐ |
|
Accelerated
filer ☐ |
Non-accelerated filer ☒ |
|
Smaller
reporting company
☒ |
Emerging
growth company
☐ |
|
|
If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act. ☐
Indicate
by check mark whether the registrant is a shell company (as defined
in Rule 12b-2 of the Exchange Act). ☐ Yes ☒
No
As of
November 11, 2022, there were
117,449,755 shares
of $0.001 par value Common Stock outstanding.
DOCUMENTS
INCORPORATED BY REFERENCE: None.
TABLE
OF CONTENTS
PART I
ITEM 1. FINANCIAL STATEMENTS
AMMO,
Inc.
CONDENSED CONSOLIDATED BALANCE SHEETS
The
accompanying notes are an integral part of these condensed
consolidated financial statements.
AMMO,
Inc.
CONDENSED CONSOLIDATED STATEMENTS OF
OPERATIONS
(Unaudited)
The
accompanying notes are an integral part of these condensed
consolidated financial statements.
AMMO,
Inc.
CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS’
EQUITY
(Unaudited)
|
|
Preferred Stock |
|
|
Common Shares |
|
|
Additional |
|
|
|
|
|
|
|
|
|
Number |
|
|
Par Value |
|
|
Number |
|
|
Par Value |
|
|
Paid-In Capital |
|
|
Accumulated (Deficit) |
|
|
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of March 31, 2021 |
|
|
- |
|
|
$ |
- |
|
|
|
93,099,967 |
|
|
$ |
93,100 |
|
|
$ |
202,073,968 |
|
|
$ |
(41,819,539 |
) |
|
$ |
160,347,529 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquisition stock issuances |
|
|
- |
|
|
|
- |
|
|
|
18,500,000
|
|
|
|
18,500
|
|
|
|
132,626,500
|
|
|
|
- |
|
|
|
132,645,000
|
|
Common stock issued for exercised
warrants |
|
|
- |
|
|
|
- |
|
|
|
219,144 |
|
|
|
219
|
|
|
|
477,592 |
|
|
|
- |
|
|
|
477,811 |
|
Common stock issued for cashless
warrant exercise |
|
|
- |
|
|
|
- |
|
|
|
275,155 |
|
|
|
275 |
|
|
|
(275 |
) |
|
|
- |
|
|
|
- |
|
Common stock issued for services and
equipment |
|
|
- |
|
|
|
- |
|
|
|
750,000 |
|
|
|
750 |
|
|
|
1,499,250 |
|
|
|
- |
|
|
|
1,500,000 |
|
Employee stock awards |
|
|
- |
|
|
|
- |
|
|
|
202,500
|
|
|
|
203 |
|
|
|
699,297 |
|
|
|
- |
|
|
|
699,500 |
|
Stock grants |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
66,914 |
|
|
|
- |
|
|
|
66,914 |
|
Issuance costs |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(4,670,422
|
) |
|
|
- |
|
|
|
(4,670,422) |
|
Issuance of Series A Preferred Stock,
net of issuance costs |
|
|
1,400,000 |
|
|
|
1,400 |
|
|
|
- |
|
|
|
- |
|
|
|
34,998,600 |
|
|
|
- |
|
|
|
35,000,000 |
|
Dividends accumulated on preferred
stock |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(337,745 |
) |
|
|
(337,745 |
) |
Net income |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
9,536,660 |
|
|
|
9,536,660 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of
June 30, 2021 |
|
|
1,400,000 |
|
|
$ |
1,400 |
|
|
|
113,046,766 |
|
|
$ |
113,047 |
|
|
$ |
367,771,424 |
|
|
$ |
(32,620,624 |
) |
|
$ |
335,265,247 |
|
Balance |
|
|
1,400,000 |
|
|
$ |
1,400.00 |
|
|
|
113,046,766 |
|
|
$ |
113,047 |
|
|
$ |
367,771,424 |
|
|
$ |
(32,620,624 |
) |
|
$ |
335,265,247 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquisition stock issuances |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(29,500 |
) |
|
|
- |
|
|
|
(29,500 |
) |
Common stock issued for exercised
warrants |
|
|
- |
|
|
|
- |
|
|
|
160,998 |
|
|
|
161 |
|
|
|
343,684 |
|
|
|
- |
|
|
|
343,845 |
|
Common stock issued for cashless
warrant exercise |
|
|
- |
|
|
|
- |
|
|
|
1,752 |
|
|
|
2 |
|
|
|
(2 |
) |
|
|
- |
|
|
|
- |
|
Common stock issued for services and
equipment |
|
|
- |
|
|
|
- |
|
|
|
21,250 |
|
|
|
21 |
|
|
|
127,479 |
|
|
|
- |
|
|
|
127,500 |
|
Employee stock awards |
|
|
- |
|
|
|
- |
|
|
|
352,250 |
|
|
|
352 |
|
|
|
1,153,273 |
|
|
|
- |
|
|
|
1,153,625 |
|
Stock grants |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
65,098 |
|
|
|
- |
|
|
|
65,098 |
|
Dividends accumulated on preferred
stock |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(782,639 |
) |
|
|
(782,639 |
) |
Net income |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
14,115,512 |
|
|
|
14,115,512 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of
September 30, 2021 |
|
|
1,400,000 |
|
|
$ |
1,400 |
|
|
|
113,583,016 |
|
|
$ |
113,583 |
|
|
$ |
369,431,456 |
|
|
$ |
(19,287,751 |
) |
|
$ |
350,258,688 |
|
Balance |
|
|
1,400,000 |
|
|
$ |
1,400 |
|
|
|
113,583,016 |
|
|
$ |
113,583 |
|
|
$ |
369,431,456 |
|
|
$ |
(19,287,751 |
) |
|
$ |
350,258,688 |
|
The
accompanying notes are an integral part of these condensed
consolidated financial statements.
AMMO,
Inc.
CONDENSED CONSOLIDATED STATEMENTS OF CASH
FLOW
(Unaudited)
(Continued)
AMMO,
Inc.
CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOW
(Unaudited)
|
|
For the Six Months Ended
September 30, |
|
|
|
2022 |
|
|
2021 |
|
|
|
|
|
|
|
|
Supplemental cash
flow disclosures: |
|
|
|
|
|
|
|
|
Cash paid during
the period for: |
|
|
|
|
|
|
|
|
Interest |
|
$ |
141,131 |
|
|
$ |
308,695 |
|
Income taxes |
|
$ |
1,302,811 |
|
|
$ |
- |
|
|
|
|
|
|
|
|
|
|
Non-cash investing
and financing activities: |
|
|
|
|
|
|
|
|
Construction note payable |
|
$ |
9,804,580 |
|
|
$ |
- |
|
Insurance premium note payment |
|
$ |
2,035,519 |
|
|
$ |
2,166,852 |
|
Dividends accumulated on preferred stock |
|
$ |
136,044 |
|
|
$ |
782,639 |
|
Operating lease liability |
|
$ |
- |
|
|
$ |
501,125 |
|
Acquisition stock issuances |
|
$ |
- |
|
|
$ |
132,645,000 |
|
The
accompanying notes are an integral part of these condensed
consolidated financial statements.
AMMO,
Inc.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS
September
30, 2022 and March 31, 2022
(Unaudited)
NOTE
1 – ORGANIZATION AND
BUSINESS ACTIVITY
We
were formed under the name Retrospettiva, Inc. in November 1990 to
manufacture and import textile products, including both finished
garments and fabrics. We were inactive until the following series
of events in December 2016 and March 2017.
On
December 15, 2016, the Company’s majority shareholders sold their
common stock to Mr. Fred W. Wagenhals (“Mr. Wagenhals”) resulting
in a change in control of the Company. Mr. Wagenhals was appointed
as sole officer and the sole member of the Company’s Board of
Directors.
The
Company also approved (i) doing business in the name AMMO, Inc.,
(ii) a change to the Company’s OTC trading symbol to POWW, (iii) an
agreement and plan of merger to re-domicile and change the
Company’s state of incorporation from California to Delaware, and
(iv) a 1-for-25 reverse stock split of the issued and outstanding
shares of the common stock of the Company. These transactions were
effective as of December 30, 2016.
On
March 17, 2017, the Company entered into a definitive agreement
with AMMO, Inc. a Delaware Corporation (PRIVCO) under which the
Company acquired all of the outstanding shares of common stock of
(PRIVCO). (PRIVCO) subsequently changes its name to AMMO Munitions,
Inc.
AMMO,
Inc.
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE
2 – SUMMARY OF
SIGNIFICANT ACCOUNTING POLICIES
Accounting Basis
The
accompanying unaudited condensed consolidated financial statements
and related disclosures included in this Quarterly Report on Form
10-Q have been prepared in accordance with accounting principles
generally accepted in the United States of America (“U.S. GAAP”)
and reflect all adjustments, which consist solely of normal
recurring adjustments, needed to fairly present the financial
results for these periods. Additionally, these condensed
consolidated financial statements and related disclosures are
presented pursuant to the rules and regulations of the Securities
Exchange Commission (“SEC”).
The
accompanying condensed consolidated financial statements should be
read in conjunction with the audited consolidated financial
statements and related disclosures contained in the Company’s
Annual Report filed with the SEC on Form 10-K for the year ended
March 31, 2022. The results for the three and six month period
ended September 30, 2022 are not necessarily indicative of the
results that may be expected for the entire fiscal year.
Accordingly, certain information and note disclosures normally
included in financial statements prepared in accordance with U.S.
GAAP have been omitted pursuant to the rules and regulations of the
SEC. In the opinion of management, all adjustments have been made,
which consist only of normal recurring adjustments necessary for a
fair statement of (a) the results of operations for the three and
six month periods ended September 30, 2022 and 2021, (b) the
financial position at September 30, 2022, and (c) cash flows for
the six month periods ended September 30, 2022 and 2021.
We
use the accrual basis of accounting and U.S. GAAP and all amounts
are expressed in U.S. dollars. The Company has a fiscal year-end of
March 31st.
Unless
the context otherwise requires, all references to “Ammo”, “we”,
“us”, “our,” or the “Company” are to AMMO, Inc., a Delaware
corporation, and its consolidated subsidiaries.
Principles of Consolidation
The
condensed consolidated financial statements include the accounts of
AMMO, Inc. and its wholly owned subsidiaries. All significant
intercompany accounts and transactions are eliminated in
consolidation.
Use of Estimates
The
preparation of financial statements in conformity with U.S. GAAP
requires us to make estimates and assumptions that affect the
amounts of assets and liabilities and disclosure of contingent
assets and liabilities at the date of the balance sheet and
reported amounts of revenue and expenses during the reporting
period. Actual results could differ from those estimates.
Significant estimates made in preparing the condensed consolidated
financial statements include the valuation of allowances for
doubtful accounts, valuation of deferred tax assets, inventories,
useful lives of assets, goodwill, intangible assets, stock-based
compensation and warrant-based compensation.
AMMO,
Inc.
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Accounts Receivable and Allowance for Doubtful
Accounts
Our
accounts receivable represents amounts due from customers for
products sold and include an allowance for uncollectible accounts
which is estimated based on the aging of the accounts receivable
and specific identification of uncollectible accounts. At September
30, 2022 and March 31, 2022, we reserved $4,053,047 and $3,055,252,
respectively, of allowance for doubtful accounts.
Restricted Cash
We
consider cash to be restricted when withdrawal or general use is
legally restricted. Our restricted cash balance is comprised of
cash on deposit with banks to secure the Construction Note Payable
as discussed in Note 10 . We report restricted cash in the
Consolidated Balance Sheets as current or non-current
classification based on the expected duration of the
restriction.
License Agreements
We
are a party to a license agreement with Jesse James, a well-known
motorcycle designer, and Jesse James Firearms, LLC, a Texas limited
liability company. The license agreement grants us the exclusive
worldwide rights through April 12, 2026 to Mr. James’ image rights
and trademarks associated with him in connection with the
marketing, promotion, advertising, sale, and commercial
exploitation of Jesse James Branded Products. We agreed to pay Mr.
James royalty fees on the sale of ammunition and non-ammunition
Branded Products and to reimburse him for any out-of-pocket
expenses and reasonable travel expenses.
Patents
On
September 28, 2017, AMMO Technologies Inc. (“ATI”), an Arizona
corporation, which is 100% owned by us, merged with Hallam, Inc, a
Texas corporation, with ATI being the survivor. The primary asset
of Hallam, Inc. was an exclusive license to produce projectiles and
ammunition using the Hybrid Luminescence Ammunition Technology
under patent U.S. 8,402,896 B1 with a publication date of March 26,
2013 owned by the University of Louisiana at Lafayette. The license
was formally amended and assigned to AMMO Technologies Inc.
pursuant to an Assignment and First Amendment to Exclusive License
Agreement. Assumption Agreement dated to be effective as of August
22, 2017, the Merger closing date. This asset will be amortized
from September 2017, the first full month of the acquired rights,
through October 29, 2028.
Under
the terms of the Exclusive License Agreement, the Company is
obligated to pay a quarterly royalty to the patent holder, based on
a $ per unit basis for each round of
ammunition sold that incorporates this patented technology through
October 29, 2028. For the six months ended September 30, 2022 and
2021, the Company recognized royalty expenses of $80,546 and $3,404, respectively under this
agreement.
AMMO,
Inc.
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
On
October 5, 2018, we completed the acquisition of SW Kenetics Inc.
ATI succeeded all of the assets of SW Kenetics, Inc. and assumed
all of the liabilities.
The
primary asset of SW Kenetics Inc. was a pending patent for modular
projectiles. All rights to patent pending application were assigned
and transferred to AMMO Technologies, Inc. pursuant to Intellectual
Property Rights Agreement on September 27, 2018.
We
intend to continue building our patent portfolio to protect our
proprietary technologies and processes, and will file new
applications where appropriate to preserve our rights to
manufacture and sell our branded lines of ammunition.
Other Intangible Assets
On
March 15, 2019, Enlight Group II, LLC d/b/a Jagemann Munition
Components, a wholly owned subsidiary of AMMO, Inc., completed its
acquisition of assets of Jagemann Stamping Company’s ammunition
casing manufacturing and sales operations pursuant to the terms of
the Amended and Restated Asset Purchase Agreement. The intangible
assets acquired include a tradename, customer relationships, and
intellectual property.
On
April 30, 2021, we entered into an agreement and plan of merger
(the “Merger Agreement”), by and among the Company, SpeedLight
Group I, LLC, a Delaware limited liability company and a wholly
owned subsidiary of the Company and Gemini Direct Investments, LLC,
a Nevada limited liability company. Whereby SpeedLight Group I, LLC
merged with and into Gemini Direct Investments, LLC, with
SpeedLight Group I, LLC surviving the merger as a wholly owned
subsidiary of the Company. At the time of the Merger, Gemini Direct
Investments, LLC had nine (9) subsidiaries, all of which are
related to Gemini’s ownership of Gunbroker.com, an online auction
marketplace dedicated to firearms, hunting, shooting, and related
products. The intangible assets acquired include a tradename,
customer relationships, intellectual property, software and domain
names.
Impairment of Long-Lived Assets
We
continually monitor events and changes in circumstances that could
indicate carrying amounts of long-lived assets may not be
recoverable. When such events or changes in circumstances are
present, we assess the recoverability of long-lived assets by
determining whether the carrying value of such assets will be
recovered through undiscounted expected future cash flows. If the
total of the future cash flows is less than the carrying amount of
those assets, we recognize an impairment loss based on the excess
of the carrying amount over the fair value of the assets. Assets to
be disposed of are reported at the lower of the carrying amount or
the fair value less costs to sell. No impairment expense was
recognized for the three and six months ended September 30, 2022
and 2021.
Revenue Recognition
We generate revenue from the production and sale of ammunition,
ammunition casings, and marketplace fee revenue, which includes
auction revenue, payment processing revenue, and shipping income.
We recognize revenue according to Accounting Standard Codification
– Revenue from Contract with Customers (“ASC 606”). When the
customer obtains control over the promised goods or services, we
record revenue in the amount of consideration that we can expect to
receive in exchange for those goods and services. We apply the
following five-step model to determine revenue recognition:
|
● |
Identification
of a contract with a customer |
|
● |
Identification
of the performance obligations in the contact |
|
● |
Determination
of the transaction price |
|
● |
Allocation
of the transaction price to the separate performance
allocation |
|
● |
Recognition
of revenue when performance obligations are satisfied |
AMMO,
Inc.
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
We
only apply the five-step model when it is probable that we will
collect the consideration we are entitled to in exchange for the
goods or services it transfers to the customer. At contract
inception and once the contract is determined to be within the
scope of ASC 606, we assess the goods or services promised within
each contract and determine those that are performance obligations,
and assess whether each promised good or service is distinct. Our
contracts contain a single performance obligation and the entire
transaction price is allocated to the single performance
obligation. We recognize as revenues the amount of the transaction
price that is allocated to the respective performance obligation
when the performance obligation is satisfied or as it is satisfied.
Accordingly, we recognize revenues (net) when the customer obtains
control of our product, which typically occurs upon shipment of the
product or the performance of the service. In the year ended March
31, 2021, we began accepting contract liabilities or deferred
revenue. We included Deferred Revenue in our Accrued Liabilities.
We will recognize revenue when the performance obligation is
met.
For
the three and six months ended September 30, 2022, the Company’s
customers that comprised more than ten percent (10%) of total
revenues and accounts receivable were as follows:
SCHEDULE OF CONCENTRATION OF
RISKS
|
|
Revenues
at September 30, 2022
|
|
|
Accounts Receivable |
|
PERCENTAGES |
|
Three Months
Ended |
|
|
Six Months Ended |
|
|
September 30,
2022 |
|
|
March 31,
2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Customers: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
A |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
11.8 |
% |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
11.8 |
% |
Disaggregated
Revenue Information
The
following table represent a disaggregation of revenue from
customers by category. We attribute net sales to categories by
product or services types; ammunition, ammunition casings, and
marketplace fees. We note that revenue recognition processes are
consistent between product and service type, however, the amount,
timing and uncertainty of revenue and cash flows may vary by each
product type due to the customers of each product and service
type.
SCHEDULE OF DISAGGREGATED REVENUE FROM CUSTOMERS BY
SEGMENT
|
|
September 30,
2022 |
|
|
September
30, 2021 |
|
|
September
30, 2022 |
|
|
September
30, 2021 |
|
|
|
For the Three Months Ended |
|
|
For the Six Months Ended |
|
|
|
September 30,
2022 |
|
|
September
30, 2021 |
|
|
September
30, 2022 |
|
|
September
30, 2021 |
|
Ammunition Sales |
|
$ |
29,386,969 |
|
|
$ |
40,208,402 |
|
|
$ |
70,356,852 |
|
|
$ |
68,560,182 |
|
Marketplace fee
revenue |
|
|
14,562,694 |
|
|
|
16,777,216 |
|
|
|
31,067,640 |
|
|
|
29,049,282 |
|
Ammunition Casings Sales |
|
|
4,338,896 |
|
|
|
4,016,467 |
|
|
|
7,620,093 |
|
|
|
7,868,953 |
|
Total
Sales |
|
$ |
48,288,559 |
|
|
$ |
61,002,085 |
|
|
$ |
109,044,585 |
|
|
$ |
105,478,417 |
|
Ammunition
products are sold through “Big Box” retailers, manufacturers, local
ammunition stores, and shooting range operators. We also sell
directly to customers online. In contrast, our ammunition casings
products are sold to manufacturers. Marketplace fees are generated
through our GunBroker.com online auction marketplace.
Advertising Costs
We
expense advertising costs as they are incurred in selling and
marketing expenses of operating expenses. Marketplace advertising
costs are expenses as they are incurred in cost of revenues. We
incurred advertising expenses of $695,537 and $55,194 for the six
months ended September 30, 2022 and 2021, respectively, recognized
in selling and marketing expenses and $220,219 and $72,711 of marketplace
advertising expenses recognized in cost of revenues for the six
months ended September 30, 2022 and 2021, respectively.
Fair Value of Financial Instruments
Fair
value estimates discussed herein are based upon certain market
assumptions and pertinent information available to us as of
September 30, 2022. The respective carrying value of certain
on-balance-sheet financial instruments approximated their fair
value. These financial instruments include cash, accounts
receivable, accounts payable, construction note payable and amounts
due to related parties. Fair values were assumed to approximate
carrying values because they are short term in nature and their
carrying amounts approximate fair values or they are payable on
demand.
Inventories
We
state inventories at the lower of cost or net realizable value. We
determine cost using the average cost method. Our inventory
consists of raw materials, work in progress, and finished goods.
Cost of inventory includes cost of parts, labor, quality control,
and all other costs incurred to bring our inventories to condition
ready to be sold. We periodically evaluate and adjust inventories
for obsolescence.
AMMO,
Inc.
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Property and Equipment
We
state property and equipment at cost, less accumulated
depreciation. We capitalize major renewals and improvements, while
we charge minor replacements, maintenance, and repairs to current
operations. We compute depreciation by applying the straight-line
method over estimated useful lives, which are generally five to ten
years.
Compensated Absences
We
accrue a liability for compensated absences in accordance with
Accounting Standards Codification 710 – Compensation – General
(“ASC 710”).
Research and
Development
To
date, we have expensed all costs associated with developing our
product specifications, manufacturing procedures, and products
through our cost of products sold, as this work was done by the
same employees who produced the finished product. We anticipate
that it may become necessary to reclassify research and development
costs into our operating expenditures for reporting purposes as we
begin to develop new technologies and lines of
ammunition.
Stock-Based Compensation
We
account for stock-based compensation at fair value in accordance
with Accounting Standards Codification 718 – Compensation – Stock
Compensation (“ASC 718”). Which requires the measurement and
recognition of compensation expense for all share-based payment
awards to employees and directors. Stock-based compensation is
recognized on a straight line basis over the vesting periods and
forfeitures are recognized in the periods they occur. There were
338,375 and 558,375 shares of
common stock issued to employees, members of the Board of
Directors, and members of our advisory committee for services
during the three and six months ended September 30, 2022
Concentrations of Credit Risk
Accounts
at banks are insured by the Federal Deposit Insurance Corporation
(“FDIC”) up to $250,000. As of September
30, 2022, our bank account balances exceeded federally insured
limits.
Income Taxes
We
file federal and state income tax returns in accordance with the
applicable rules of each jurisdiction. We account for income taxes
under the asset and liability method in accordance with Accounting
Standards Codification 740 – Income Taxes (“ASC 740”). The
provision for income taxes includes federal, state, and local
income taxes currently payable, and deferred taxes. We recognize
deferred tax assets and liabilities for the future tax consequences
attributable to differences between the financial statement
carrying amounts of existing assets and liabilities and their
respective tax basis. We measure deferred tax assets and
liabilities using enacted tax rates expected to apply to taxable
amounts in years in which those temporary differences are expected
to be recovered or settled. If it is more likely than not that some
portion or all of a deferred tax asset will not be realized, a
valuation allowance is recognized. In accordance with ASC 740, we
recognize the effect of income tax positions only if those
positions are more likely than not of being sustained. We measure recognized
income tax positions at the largest amount that is greater than 50%
likely of being realized. We reflect changes in recognition
or measurement in the period in which the change in judgment
occurs.
Excise Tax
As a
result of regulations imposed by the Federal Government for sales
of ammunition to non-government U.S. entities, we charge and
collect an 11% excise tax for all
products sold into these channels. During the six months ended
September 30, 2022 and 2021, we recognized approximately $6.1 million and $6.3 million respectively, in
excise taxes. For ease in selling to commercial markets, excise tax
is included in our unit price for the products sold. We record this
through net sales and expense the offsetting tax expense to cost of
goods sold.
AMMO,
Inc.
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Contingencies
Certain
conditions may exist as of the date the condensed consolidated
financial statements are issued that may result in a loss to us but
will only be resolved when one or more future events occur or fail
to occur. We assess such contingent liabilities, and such
assessment inherently involves an exercise of judgment. In
assessing loss contingencies related to legal proceedings that are
pending against us or unasserted claims that may result in such
proceedings, we evaluate the perceived merits of any legal
proceedings or unasserted claims and the perceived merits of the
amount of relief sought or expected to be sought
therein.
If
the assessment of a contingency indicates that it is probable that
a material loss has been incurred and the amount of the liability
is reasonably estimated, the estimated liability would be accrued
in our condensed consolidated financial statements. If the
assessment indicates that a potentially material loss contingency
is not probable but is reasonably possible, or is probable but
cannot be estimated, then the nature of the contingent liability,
together with an estimate of range of possible loss if determinable
and material, would be disclosed. On September 24, 2019, the
Company received notice that a former employee that had voluntarily
terminated filed a complaint against the Company, and certain
individuals, with the U.S. Department of Labor (“DOL”). The
Complaint in alleges that the individual reported potential
violations of SEC rules and regulations by management and that as a
result of such disclosures, the individual experienced a hostile
work environment; that the Company lacks sufficient internal
controls, and that the individual was the victim of retaliation and
constructive discharge after being removed as a director by
majority vote of the shareholders. The claims were investigated by
a newly appointed Special Investigative Committee made up of
independent directors represented by special independent legal
counsel. The Special Investigative Committee and legal counsel
found the material claims were unsubstantiated, including those
concerning alleged SEC violations, and recommended enhancements to
certain corporate governance charter documents and processes which
the Company promptly implemented. The Parties participated in a
successful mediation at the end of June 2022 and all matters
relating to this former employee/claimant were confidentially
resolved with the lawsuit dismissed with prejudice (Order pending).
The settlement was covered by our Employment Practices Liability
Policy and did not amount to a material amount. On February 10,
2022, AMMO filed a Texas state court complaint against Expansion
Industries pursing eight (8) claims in pursuit of recovery of
AMMO’s in primer acquisition deposit monies (i.e., Breach of
Contract, Common Law Fraud, Violations of Texas Theft Liability
Act, Conversion, Negligent Misrepresentation, Unjust Enrichment,
Money Had and Received and Constructive Trust). AMMO has since
moved aggressively to further the process, including successfully
garnishing a portion of the deposit monies in Expansion bank
accounts, filing a Motion for Summary Judgement, continuing to
pursue written discovery, and amending the Complaint to add
Expansion principal as an individual party. The putative primer
manufacturer settled the two related lawsuits in September 2022 by
repaying all deposit monies due AMMO, in addition to payment of
principally all fees and costs incurred by the Company in pursuit
of the resolution. The principal lawsuit and AMMO’s garnishment
action adverse the defendant were dismissed with prejudice. Along
with countless other suppliers of Remington Outdoors, AMMO was
served with an avoidance claim lawsuit by the bankruptcy trustee.
AMMO presented substantial “ordinary course” defense evidence to
the Trustee and the case was settled for a nominal sum in September
2022, with the lawsuit dismissed with prejudice. AMMO is defended
two contract arbitration cases adverse former employees that are
presently in discovery, one involving an employee terminated for
cause and the second action involving a termination without cause
wherein the former employee is seeking contract wages, commissions
and allegedly earned common stock. The Company also received notice
in October that an OSHA whistleblower complaint had been filed with
the US Department of Labor by an employee that had been terminated
for cause. The regulatory filing was received after AMMO refused to
capitulate to the former employee’s demands. AMMO is presently
reviewing the OSHA Complaint for discussion with its insurer and
potential participation in a voluntary mediation. There were no
other known contingencies at September 30, 2022.
AMMO,
Inc.
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE
3 – INCOME PER COMMON
SHARE
We
calculate basic income per share using the weighted-average number
of shares of common stock outstanding during each reporting period.
Diluted loss per share includes potentially dilutive securities,
such as outstanding options and warrants. We use the treasury stock
method, in the determination of dilutive shares outstanding during
each reporting period. We have issued warrants to purchase
2,821,634 shares of
common stock. Due to the net loss attributable to common
shareholders for the three months ended September 30, 2022,
potentially dilutive securities, which consists of 1,319,091
common stock purchase warrants and 18,469 equity
incentive awards have been excluded from the dilutive EPS
calculation as the effect would be antidilutive. The Company
excluded warrants of 150,000 for the six months ended
September 30, 2022, from the weighted average diluted common shares
outstanding because their inclusion would have been
antidilutive.
SCHEDULE OF INCOME/(LOSS) PER COMMON
SHARE
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
|
|
For the Three Months Ended
September 30, |
|
|
For the Six Months Ended
September 30, |
|
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income/(loss) |
|
$ |
(803,507 |
) |
|
$ |
14,115,512 |
|
|
$ |
2,449,520 |
|
|
$ |
23,652,172 |
) |
Less: Preferred
stock dividends |
|
|
(782,639 |
) |
|
|
(782,639 |
) |
|
|
(1,556,771 |
) |
|
|
(1,120,384 |
) |
Net
income/(loss) attributable to common stockholders |
|
$ |
(1,586,146 |
) |
|
$ |
13,332,873 |
|
|
$ |
892,749 |
|
|
$ |
22,531,788 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares of common stock – Basic |
|
|
116,927,607 |
|
|
|
113,174,363 |
|
|
|
116,744,972 |
|
|
|
109,545,553 |
|
Effect of dilutive
common stock purchase warrants |
|
|
- |
|
|
|
1,922,749 |
|
|
|
1,300,609 |
|
|
|
1,916,315 |
|
Effect
of dilutive contingently issuable common stock (1) |
|
|
- |
|
|
|
1,500,000 |
|
|
|
- |
|
|
|
1,262,295 |
|
Effect of dilutive equity incentive awards |
|
|
- |
|
|
|
124,837 |
|
|
|
18,038 |
|
|
|
124,658 |
|
Weighted
average shares of common stock - Diluted |
|
|
116,927,607 |
|
|
|
116,721,949 |
|
|
|
118,063,619 |
|
|
|
112,848,821 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income/(loss)
per share attributable to common stockholders – basic |
|
$ |
(0.01 |
) |
|
$ |
0.12 |
|
|
$ |
0.01 |
|
|
$ |
0.21 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income/(loss)
per share attributable to common stockholders – diluted |
|
$ |
(0.01 |
) |
|
$ |
0.11 |
|
|
$ |
0.01 |
|
|
$ |
0.20 |
|
|
(1) |
Weighted
average of contingently issuable shares measured from the effective
date of merger, April 30, 2021 |
NOTE
4 – INVENTORIES
At
September 30, 2022 and March 31, 2022, the inventory balances are
composed of:
SCHEDULE OF INVENTORIES
|
|
September 30, 2022 |
|
|
March 31, 2022 |
|
Finished product |
|
$ |
16,979,313 |
|
|
$ |
6,167,318 |
|
Raw materials |
|
|
34,413,831 |
|
|
|
33,924,813 |
|
Work in
process |
|
|
17,213,864 |
|
|
|
18,924,021 |
|
Inventory net |
|
$ |
68,607,008 |
|
|
$ |
59,016,152 |
|
NOTE
5 – PROPERTY AND
EQUIPMENT
We
state equipment at historical cost less accumulated depreciation.
We compute depreciation using the straight-line method at rates
intended to depreciate the cost of assets over their estimated
useful lives, which are generally five to ten years. Upon
retirement or sale of property and equipment, we remove the cost of
the disposed assets and related accumulated depreciation from the
accounts and any resulting gain or loss is credited or charged to
other income. We charge expenditures for normal repairs and
maintenance to expense as incurred.
We
capitalize additions and expenditures for improving or rebuilding
existing assets that extend the useful life. Leasehold improvements
made either at the inception of the lease or during the lease term
are amortized over the shorter of their economic lives or the lease
term including any renewals that are reasonably assured.
AMMO,
Inc.
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Property
and Equipment consisted of the following at September 30, 2022 and
March 31, 2022:
SCHEDULE OF
EQUIPMENT
|
|
September 30, 2022 |
|
|
March 31, 2022 |
|
Building |
|
$ |
26,394,651 |
|
|
$ |
- |
|
Construction in progress |
|
|
1,837,308
|
|
|
|
14,335,371
|
|
Leasehold Improvements |
|
|
257,009 |
|
|
|
257,009 |
|
Furniture and Fixtures |
|
|
362,806 |
|
|
|
343,014 |
|
Vehicles |
|
|
153,254 |
|
|
|
153,254 |
|
Equipment |
|
|
36,818,229 |
|
|
|
32,524,850 |
|
Tooling |
|
|
143,710 |
|
|
|
143,710 |
|
Total property and equipment |
|
$ |
65,966,967 |
|
|
$ |
47,757,208 |
|
Less
accumulated depreciation |
|
|
(12,180,849 |
) |
|
|
(10,119,402 |
) |
Net property
and equipment |
|
$ |
53,786,118 |
|
|
$ |
37,637,806 |
|
Depreciation Expense for the three and six months ended September
30, 2022 totaled $1,025,085, and $2,061,448, respectively. Depreciation
Expense for the three and six months ended September 30, 2021
totaled $1,101,987, and $2,054,938, respectively.
NOTE
6 – FACTORING
LIABILITY
On
July 1, 2019, we entered into a Factoring and Security Agreement
with Factors Southwest, LLC (“FSW”). FSW may purchase from time to
time the Company’s Accounts Receivables with recourse on an account
by account basis. The twenty-four month agreement contains a
maximum advance amount of $5,000,000
on 85% of
eligible accounts and has an annualized interest rate of the Prime
Rate published from time to time by the Wall Street Journal plus
4.5%. The agreement contains fee of 3%
($150,000) of
the Maximum Facility assessed to the Company. Our obligations under
this agreement are secured by present and future accounts
receivables and related assets, inventory, and equipment. The
Company has the right to terminate the agreement, with 30 days
written notice, upon obtaining a non-factoring credit facility.
This agreement provides the Company with the ability to convert our
account receivables into cash. As of September 30, 2022, the
outstanding balance of the Factoring Liability was $794,389. For the three and six
months ended September 30, 2022, interest expense recognized on the
Factoring Liability was $9,119 and
$68,935
including $37,500 of
amortization of the commitment fee and for the three and six months ended
September 30, 2021, interest expense recognized on the Factoring
Liability was $70,795 and
$112,374,
respectively, including $37,500 of
amortization of the commitment fee.
On
June 17, 2021, this agreement was amended which extended the
maturity date to June 17, 2023.
NOTE
7 – INVENTORY CREDIT
FACILITY
On
June 17, 2020, we entered into a Revolving Inventory Loan and
Security Agreement with FSW. FSW will establish a revolving credit
line, and make loans from time to time to the Company for the
purpose of providing capital. The twenty-four month agreement
secured by our inventory, among other assets, contains a maximum
loan amount of $1,750,000 on
eligible inventory and has an
annualized interest rate of the greater of the three-month LIBOR
rate plus 3.09% or 8%. The agreement contains a fee of
2%
of the maximum loan amount ($35,000)
assessed to the Company. On July 31, 2020, the Company amended its
Revolving Loan and Security Agreement to increase the maximum
inventory loan amount to $2,250,000.
As of September 30, 2022, there was no outstanding balance of the
Inventory Credit Facility. Interest expense recognized on the
Inventory Credit Facility for the six months ended September 30,
2022 and 2021 was $6,580
and $21,333
(including $8,561 of amortization of
the annual fee), respectively.
NOTE
8 – LEASES
We
lease office, manufacturing, and warehouse space in Scottsdale, AZ,
Atlanta and Marietta, GA, and Manitowoc, WI under contracts we
classify as operating leases. None of our leases are financing
leases. The Scottsdale lease does not include a renewal option. In
August of 2021 we extended the lease of our Atlanta offices through
May of 2027, accordingly we increased our Right of Use Assets and
Operating Lease Liabilities by $501,125 at
September 30, 2021. In January of 2022, we extended the lease of
our second Manitowoc, WI location and increased our Right of Use
Assets and Operating Lease Liabilities by $308,326.
As of
September 30, 2022 and March 31, 2022, total Right of Use Assets
were $2,393,817 and $2,791,850, respectively. As of
September 30, 2022 and March 31, 2022, total Operating Lease
Liabilities were $2,519,596 and $2,922,780, respectively.
The current portion of our Operating Lease Liability on September
30, 2022 and March 31, 2022 is $836,544 and
$831,429
respectively and is reported as a current liability. The remaining
$1,683,052 of
the total $2,519,596 for the quarter
ended September 30, 2022 and the $2,091,351 of
the total $2,922,780 for the year
ended March 31, 2022 of the Operating Lease Liability is presented
as a long-term liability net of the current portion.
AMMO,
Inc.
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
The
weighted average remaining lease term and weighted average discount
rate for operating leases were 3.2 years and
10.0%,
respectively.
Future
minimum lease payments under non-cancellable leases as of September
30, 2022 are as follows:
SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS
UNDER NON-CANCELLABLE LEASES
Years Ended March 31, |
|
|
|
2023
(1) |
|
$ |
524,011 |
|
2024 |
|
|
992,620 |
|
2025 |
|
|
796,066 |
|
2026 |
|
|
351,962 |
|
2027 |
|
|
257,508 |
|
Thereafter |
|
|
43,660 |
|
Total Lease Payments |
|
|
2,965,827 |
|
Less: Amount
Representing Interest |
|
|
(446,231 |
) |
Present
value of lease liabilities |
|
$ |
2,519,596 |
|
|
(1) |
This
amount represents future lease payments for the remaining six
months of fiscal year 2023. It does not include any lease payments
for the six months ended September 30, 2022. |
NOTE
9 – NOTES PAYABLE –
RELATED PARTY
For
the three and six months ended September 30, 2022, the Company made
$169,110 and $334,374 in principal payments,
respectively, in connection with the Amended Note B, an amended
related party note payable with Jagemann Stamping Company (“JSC”).
We entered into the Amended Note B with JSC on November 4, 2020 and
the note matures on June 26, 2023. We recognized $12,745 and $31,397 in respective
interest expenses for the three and six months ended September 30,
2022, respectively.
AMMO,
Inc.
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE
10 – CONSTRUCTION NOTE
PAYABLE
On
October 14, 2021, we entered into a Construction Loan Agreement
(the “Loan Agreement”) with Hiawatha National Bank (“Hiawatha”).
The Loan Agreement specifies that Hiawatha may lend up to
$11,625,000 to the Borrower to pay a
portion of the construction costs of an approximately 160,000 square foot manufacturing
facility to be constructed our property (the “Loan”). The first
advance of Loan funds by Hiawatha was made on October 14, 2021 in
the amount of $329,843. We expect to
receive further advances of Loan funds approximately every month as
our “owner’s equity” is fully funded into the ongoing new plant
construction project. The Loan is an advancing term loan and not a
revolving loan so any portion of the principal repaid cannot be
reborrowed.
Additionally,
on October 14, 2021, we issued a Promissory Note in favor of
Hiawatha (the “Note”) in the amount of up to $11,625,000 with an interest rate of
four and one-half percent (4.5%). The maturity date of the
Note is October 14, 2026.
We
can prepay the Note in whole or in part starting in July 2022 with
a prepayment premium of one percent (1%) of
the principal being prepaid.
The Loan Agreement contains
customary events of default including, but not limited to, a
failure to make any payments pursuant to the Loan Agreement or
Note, a failure to complete construction of the project, a lien of
$100,000 or more against the property, or a transfer of the
property without Hiawatha’s consent. Upon the occurrence of an
event of default, among other remedies, the amounts due pursuant to
the Loan can be accelerated, Hiawatha can foreclose on the property
pursuant to the mortgage, and a late charge of five percent (5%) of
the amount due will be owed with all amounts then owed pursuant to
the Note bearing interest at an increased rate.
For
the six months ended September 30, 2022, approximately $10.9 million of Loan
funds were advanced including $1.0 million of
cash collateral or restricted cash as security for the Loan. The
restricted cash can be released per the terms documented in the
Loan Agreement filed with the Commission on Form 10-Q on February
14, 2022.
NOTE
11 – CAPITAL
STOCK
Our authorized capital consists of 200,000,000 shares
of common stock with a par value of $0.001 per share.
During
the six month period ended September 30, 2022, we issued 789,008
shares of common stock as follows:
|
● |
99,762
shares were issued for cashless exercise of 100,000
warrants |
|
● |
12,121
shares were issued for the exercise of warrants for a total value
of $24,242 |
|
● |
677,125
shares valued at $2,351,438
were issued to employees, members of the Board of Directors, and
members of the Advisory Committee as compensation |
AMMO,
Inc.
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
At
September 30, 2022, outstanding and exercisable stock purchase
warrants consisted of the following:
SCHEDULE OF OUTSTANDING AND EXERCISABLE STOCK
PURCHASE WARRANTS
|
|
Number of
Shares |
|
|
Weighted
Average
Exercise
Price |
|
|
Weighted
Average
Life
Remaining
(Years)
|
|
Outstanding at March 31, 2022 |
|
|
2,933,755 |
|
|
$ |
2.32 |
|
|
|
2.29 |
|
Granted |
|
|
- |
|
|
|
- |
|
|
|
- |
|
Exercised |
|
|
(112,121 |
) |
|
|
0.23 |
|
|
|
- |
|
Forfeited or
cancelled |
|
|
- |
|
|
|
- |
|
|
|
- |
|
Outstanding at September 30,
2022 |
|
|
2,821,634 |
|
|
$ |
2.40 |
|
|
|
1.79 |
|
Exercisable at September 30,
2022 |
|
|
2,821,634 |
|
|
$ |
2.40 |
|
|
|
1.79 |
|
As of
September 30, 2022, we had 2,821,634 warrants outstanding.
Each warrant provides the
holder the right to purchase up to one share of our Common Stock at
a predetermined exercise price. The outstanding warrants consist of
(1) warrants to purchase 911 shares
of Common Stock at an exercise price of $1.65 per share until April
2025; (2) warrants to purchase 1,809,446
shares of our Common Stock at an exercise price of $2.00 per share consisting of
32% of the warrants until August 2024, and 68% until February 2026;
(3) warrants to purchase 474,966
shares of Common Stock at an exercise price of $2.40 until September 2024;
(4) warrants to purchase 386,311
shares of Common Stock at an exercise price of $2.63 until November 2025,
and (5) warrants to purchase 150,000
shares of Common Stock at an exercise price of $6.72 until February
2024.
AMMO,
Inc.
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE
12 – PREFERRED
STOCK
On
May 18, 2021, the Company filed a Certificate of Designations (the
“Certificate of Designations”) with the Secretary of State of the
State of Delaware to establish the preferences, voting powers,
limitations as to dividends or other distributions, qualifications,
terms and conditions of redemption and other terms and conditions
of the Series A Preferred Stock.
The
Company will pay cumulative cash dividends on the Series A
Preferred Stock when, as and if declared by its board of directors
(or a duly authorized committee of its board of directors), only
out of funds legally available for payment of dividends. Dividends
on the Series A Preferred Stock will accrue on the stated amount of
$25.00 per share of
the Series A Preferred Stock at a rate per annum equal to 8.75% (equivalent to $2.1875 per
year), payable quarterly in arrears. Dividends on the Series A
Preferred Stock declared by our board of directors (or a duly
authorized committee of our board of directors) will be payable quarterly in arrears on
March 15, June 15, September 15 and December 15.
Generally,
the Series A Preferred Stock is not redeemable by the Company prior
to May 18, 2026. However, upon a change of control or delisting
event (each as defined in the Certificate of Designations), the
Company will have a special option to redeem the Series A Preferred
Stock for a limited period of time.
Preferred
dividends accumulated as of September 30, 2022 were $136,044. On August
17, 2022, the Board of Directors of the Company declared a dividend
on the Company’s Series A Preferred Stock for the period beginning
June 15, 2022 through and including September 14, 2022 payable on
September 15, 20221 to holders of record of Series A Preferred
Stock on August 31, 2022 equal to $$0.55902778
per share. Dividends totaling $782,639 were paid on September
15, 2022. On May 12, 2022, the Board of Directors of the Company
declared a dividend on the Company’s Series A Preferred Stock for
the period beginning March 15, 2022 through and including June 14,
2022 payable on June 15, 2022 to holders of record of Series A
Preferred Stock on May 31, 2022 equal to $0.559027777777778
per share. Dividends totaling $782,639 were paid on June 15,
2022.
AMMO,
Inc.
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE
13 – ACQUISITION
Gemini Direct Investments, LLC
On
April 30, 2021 (the “Effective Date”) we entered into an agreement
and plan of merger (the “Merger Agreement”), by and among the
Company, SpeedLight Group I, LLC, a Delaware limited liability
company and a wholly owned subsidiary of the Company (“Sub”),
Gemini Direct Investments, LLC, a Nevada limited liability company
(“Gemini”), and Steven F. Urvan, an individual (the “Seller”),
whereby Sub merged with and into Gemini, with Sub surviving the
merger as a wholly owned subsidiary of the Company (the “Merger”).
At the time of the Merger, Gemini had nine (9) subsidiaries, all of
which are related to Gemini’s ownership of the GunBroker.com
business. GunBroker.com is an on-line auction marketplace dedicated
to firearms, hunting, shooting, and related products. The Merger
was completed on the Effective Date.
In
consideration of the Merger, on the terms and subject to the
conditions set forth in the Merger Agreement, on the Effective
Date, (i) the Company assumed and repaid an aggregate amount of
indebtedness of Gemini and its subsidiaries equal to $50,000,000 (the
“Assumed Indebtedness”); and, (ii) the issued and outstanding
membership interests in Gemini (the “Membership Interests”), held
by the Seller, automatically converted into the right to receive
(A) $50,000,000 (the “Cash
Consideration”), and (B) 20,000,000 shares of
common stock of the Company, $0.001 par value
per share (the “Stock Consideration”).
In
connection with the Merger Agreement, the Company and the Seller
agreed that the Stock Consideration consisted of: (a) 14,500,000
shares issued without being held in escrow or requiring prior
stockholder approval; (b) 4,000,000
shares issued subject to the Pledge and Escrow Agreement; and (c)
1,500,000
shares that will not be issued prior to the Company obtaining
stockholder approval for the issuance (the “Additional
Securities”).
The
total estimated consideration consisted of cash payment of
$50,000,000 less
$1,350,046 of
acquired cash, a working capital adjustment of $2,000,000, debt
assumption and repayment upon closing of $50,000,000,
contingent consideration of $10,755,000 for
1,500,000 Additional
Securities, and 18,500,000
shares of AMMO Inc. Common Stock. The shares were valued at
$7.17 per share,
the five-day average closing price of the Company’s Common Stock
immediately preceding the signing of the binding
agreement.
Pursuant
to the Merger Agreement, the Company completed a Post-Closing
Adjustment following the close of the Merger equal to the Closing
Working Capital minus the Estimated Working Capital at closing of
the Merger. Accordingly, the Company received a cash payment of
$129,114 and adjusted
the $2,000,000 Estimated
Working Capital Adjustment in the fair value of the consideration
transferred to $1,870,886.
In
accordance with the acquisition method of accounting for business
combinations, the assets acquired, and the liabilities assumed have
been recorded at their respective fair values. The consideration in
excess of the fair values of assets acquired, and liabilities
assumed are recorded as goodwill.
The
fair value of the consideration transferred was valued as of the
date of the acquisition as follows:
SCHEDULE OF FAIR VALUE OF CONSIDERATION
TRANSFERRED
|
|
|
|
|
Cash |
|
$ |
48,649,954 |
|
Working capital adjustment |
|
|
1,870,886 |
|
Contingent consideration |
|
|
10,755,000 |
|
Common stock |
|
|
132,645,000 |
|
Assumed
debt |
|
|
50,000,000 |
|
|
|
|
|
|
Fair value of Patent |
|
$ |
243,920,840 |
|
The
allocation for the consideration recorded for the acquisition is as
follows:
SCHEDULE OF ALLOCATION FOR
CONSIDERATION
|
|
|
|
|
Accounts receivable,
net |
|
$ |
17,002,362 |
|
Prepaid expenses |
|
|
478,963 |
|
Equipment |
|
|
1,051,980 |
|
Deposits |
|
|
703,389 |
|
Other
Intangible assets(1) |
|
|
146,617,380 |
|
Goodwill(1) |
|
|
90,870,094 |
|
Right of use assets – operating
leases |
|
|
612,727 |
|
Accounts payable |
|
|
(12,514,919 |
) |
Accrued expenses |
|
|
(196,780 |
) |
Operating lease
liability |
|
|
(704,356 |
) |
|
|
|
|
|
Total
Consideration |
|
$ |
243,920,840 |
|
(1) |
Other
intangible assets consist of Tradenames, Customer Relationships,
Intellectual Property, and other tangible assets related to the
acquired business. |
Unaudited
Pro Forma Results of Operations
This pro forma results of operations gives effect to the
acquisition as if it had occurred April 1, 2021. Material pro forma
adjustments include the removal of approximately $1.8
million of interest expenses and debt discount amortization and the
addition of approximately $0.9
million depreciation and amortization expenses.
SCHEDULE OF UNAUDITED PRO FORMA RESULTS OF
OPERATIONS
INCOME STATEMENT DATA |
|
For
the Six Months
Ended September 30, 2022
|
|
|
|
|
|
Net revenues |
|
$ |
113,523,838 |
|
Net income |
|
$ |
28,314,732 |
|
AMMO,
Inc.
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
We
recorded approximately $1.3
million in transaction costs during the six months ended September
30, 2021.
NOTE
14 – GOODWILL AND
INTANGIBLE ASSETS
During
our fiscal year ended March 31, 2022, we recorded $90,870,094 of Goodwill generated from our
Merger with Gemini.
Amortization
expenses related to our intangible assets for the three and six
months ended September 30, 2022 were $3,266,760 and
$6,533,520,
respectively. Amortization
expenses related to our intangible assets for the three and six
months ended September 30, 2021 were $3,535,805 and
$6,057,322.
SCHEDULE OF INTANGIBLE
ASSETS
|
|
|
|
|
September 30, 2022 |
|
|
|
Life |
|
|
Licenses |
|
|
Patent |
|
|
Other
Intangible
Assets |
|
Licensing Agreement –
Jesse James |
|
|
5 |
|
|
$ |
125,000 |
|
|
$ |
- |
|
|
$ |
- |
|
Licensing Agreement – Jeff Rann |
|
|
5 |
|
|
|
125,000 |
|
|
|
- |
|
|
|
- |
|
Streak Visual Ammunition patent |
|
|
11.2 |
|
|
|
- |
|
|
|
950,000 |
|
|
|
- |
|
SWK patent acquisition |
|
|
15 |
|
|
|
- |
|
|
|
6,124,005 |
|
|
|
- |
|
Jagemann Munition Components: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Customer Relationships |
|
|
3 |
|
|
|
- |
|
|
|
- |
|
|
|
1,450,613 |
|
Intellectual Property |
|
|
3 |
|
|
|
- |
|
|
|
- |
|
|
|
1,543,548 |
|
Tradename |
|
|
5 |
|
|
|
- |
|
|
|
- |
|
|
|
2,152,076 |
|
GDI Acquisition: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tradename |
|
|
15 |
|
|
|
- |
|
|
|
- |
|
|
|
76,532,389 |
|
Customer List |
|
|
10 |
|
|
|
- |
|
|
|
- |
|
|
|
65,252,802 |
|
Intellectual Property |
|
|
10 |
|
|
|
- |
|
|
|
- |
|
|
|
4,224,442 |
|
Other
Intangible Assets |
|
|
5 |
|
|
|
- |
|
|
|
- |
|
|
|
607,747 |
|
|
|
|
|
|
|
|
250,000 |
|
|
|
7,074,005 |
|
|
|
151,763,617 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated amortization – Licensing
Agreements |
|
|
|
|
|
|
(250,000 |
) |
|
|
- |
|
|
|
- |
|
Accumulated amortization –
Patents |
|
|
|
|
|
|
- |
|
|
|
(1,794,519 |
) |
|
|
- |
|
Accumulated
amortization – Intangible Assets |
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
(21,750,018 |
) |
|
|
|
|
|
|
$ |
- |
|
|
$ |
5,279,486 |
|
|
$ |
130,013,599 |
|
Annual
amortization of intangible assets for the next five fiscal years
are as follows:
SCHEDULE OF ANNUAL AMORTIZATION OF INTANGIBLE
ASSET
Years Ended March 31, |
|
Estimates for
Fiscal Year |
|
2023 (1) |
|
$ |
6,561,695 |
|
2024 |
|
|
13,074,489 |
|
2025 |
|
|
12,664,775 |
|
2026 |
|
|
12,664,775 |
|
2027 |
|
|
12,553,355 |
|
Thereafter |
|
|
77,773,996 |
|
Annual amortization of intangible assets |
|
$ |
135,293,085 |
|
(1) |
This
amount represents future amortization for the remaining six months
of fiscal year 2023. It does not include any amortization for the
six months ended September 30, 2022. |
AMMO,
Inc.
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE
15 – SEGMENTS
On
April 30, 2021, we entered into an agreement and plan of merger
with Gemini, which, along with its subsidiaries, engages primarily
in the operation of an online marketplace dedicated to firearms,
hunting, shooting and related products, which created a second
reportable segment. Our Chief Executive Officer reviews financial
performance based on our two operating segments as
follows:
|
● |
Ammunition
– which consists of our manufacturing business. The Ammunition
segment engages in the design, production and marketing of
ammunition and ammunition component products. |
|
● |
Marketplace
– which consists of the GunBroker.com marketplace. In its role as
an auction site, GunBroker.com supports the lawful sale of
firearms, ammunition and hunting/shooting accessories. |
In
the current period, we began the reporting of the separate
allocation of certain corporate general and administrative expenses
including non-cash stock compensation expense, as such we have
updated the prior period disclosure herein. The following tables
set forth certain financial information utilized by management to
evaluate our operating segments for the interim period
presented:
SCHEDULE OF OPERATING
SEGMENTS
|
|
Ammunition |
|
|
Marketplace |
|
|
Corporate
and other
expenses |
|
|
Total |
|
|
|
For the Three Months Ended September 30, 2022 |
|
|
|
Ammunition |
|
|
Marketplace |
|
|
Corporate
and other
expenses |
|
|
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Revenues |
|
$ |
33,725,865 |
|
|
$ |
14,562,694 |
|
|
$ |
- |
|
|
$ |
48,288,559 |
|
Cost of Revenues |
|
|
33,353,443 |
|
|
|
2,099,407 |
|
|
|
- |
|
|
|
35,452,850 |
|
General and administrative
expense |
|
|
3,606,635 |
|
|
|
2,560,125 |
|
|
|
3,881,140 |
|
|
|
10,047,900 |
|
Depreciation
and amortization |
|
|
147,904 |
|
|
|
3,143,418 |
|
|
|
- |
|
|
|
3,291,322 |
|
Income from
Operations |
|
$ |
(3,382,117 |
) |
|
$ |
6,759,744 |
|
|
$ |
(3,881,140 |
) |
|
$ |
(503,513 |
) |
|
|
Ammunition |
|
|
Marketplace |
|
|
Corporate
and other
expenses |
|
|
Total |
|
|
|
For the Six Months Ended September 30, 2022 |
|
|
|
Ammunition |
|
|
Marketplace |
|
|
Corporate
and other
expenses |
|
|
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Revenues |
|
$ |
77,976,945 |
|
|
$ |
31,067,640 |
|
|
$ |
- |
|
|
$ |
109,044,585 |
|
Cost of Revenues |
|
|
73,690,458 |
|
|
|
4,382,756 |
|
|
|
- |
|
|
|
78,073,214 |
|
General and administrative
expense |
|
|
7,279,747 |
|
|
|
4,993,854 |
|
|
|
7,496,864 |
|
|
|
19,770,465 |
|
Depreciation
and amortization |
|
|
294,316 |
|
|
|
6,347,362 |
|
|
|
- |
|
|
|
6,641,678 |
|
Income from
Operations |
|
$ |
(3,287,576 |
) |
|
$ |
15,343,668 |
|
|
$ |
(7,496,864 |
) |
|
$ |
4,559,228 |
|
|
|
Ammunition |
|
|
Marketplace |
|
|
|
|
|
Total |
|
|
|
For the Three Months Ended September 30, 2021 |
|
|
|
Ammunition |
|
|
Marketplace |
|
|
Corporate
and other
expenses
|
|
|
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Revenues |
|
$ |
44,224,870 |
|
|
$ |
16,777,215 |
|
|
$ |
- |
|
|
$ |
61,002,085 |
|
Cost of Revenues |
|
|
32,450,484 |
|
|
|
2,335,533 |
|
|
|
- |
|
|
|
34,786,017 |
|
General and administrative
expense |
|
|
3,249,434 |
|
|
|
2,147,217 |
|
|
|
2,883,085 |
|
|
|
8,279,738 |
|
Depreciation
and amortization |
|
|
419,745 |
|
|
|
3,288,267 |
|
|
|
- |
|
|
|
3,708,012 |
|
Income from
Operations |
|
$ |
8,105,207 |
|
|
$ |
9,006,198 |
|
|
$ |
(2,883,085 |
) |
|
$ |
14,228,318 |
|
|
|
Ammunition |
|
|
Marketplace |
|
|
|
|
|
Total |
|
|
|
For the Six Months Ended September 30, 2021 |
|
|
|
Ammunition |
|
|
Marketplace |
|
|
Corporate
and other
expenses
|
|
|
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Revenues |
|
$ |
76,429,136 |
|
|
$ |
29,049,281 |
|
|
$ |
- |
|
|
$ |
105,478,417 |
|
Cost of Revenues |
|
|
56,298,732 |
|
|
|
3,992,723 |
|
|
|
- |
|
|
|
60,291,455 |
|
General and administrative
expense |
|
|
6,126,788 |
|
|
|
3,149,782 |
|
|
|
5,682,487 |
|
|
|
14,959,057 |
|
Depreciation
and amortization |
|
|
839,987 |
|
|
|
5,479,086 |
|
|
|
- |
|
|
|
6,319,073 |
|
Income from
Operations |
|
$ |
13,163,629 |
|
|
$ |
16,427,690 |
|
|
$ |
(5,682,487 |
) |
|
$ |
23,908,832 |
|
NOTE
16 – INCOME
TAXES
The
income tax provision effective tax rates were 35.0% and 46.0% for the three and six
months ended September 30, 2022 and 0.0% and 0.0% for the three and six months
ended September 30, 2021, respectively. During the three and six
months ended September 30, 2022, the effective tax rate differed
from the U.S. federal statutory rate primarily due to state income
taxes. For the three and six months ended September 30, 2021 the
effective tax rate differed from the U.S. federal statutory rate
due to our valuation. The effective tax rates increased during the
three and six months ended September 30, 2022 compared to the prior
year period due to the removal of our valuation
allowance.
The
Company has never had an Internal Revenue Service audit; therefore,
the tax periods ended December 31, 2016, December 31, 2017, and
March 31, 2018, 2019, 2020, 2021, and 2022 are subject to
audit.
NOTE
17 – RELATED PARTY
TRANSACTIONS
Through
our acquisition of Gemini, a related party relationship was created
through one of our Members of the Board of Directors by ownership
of entities that transacts with Gemini. Our Accounts Receivable
consisted of $203,233 in receivables from
these entities at September 30, 2022 . We recognized $224,808 in Marketplace Revenue for the six
months ended September 30, 2022 that was attributable to that
relationship.
NOTE 18 – SUBSEQUENT
EVENTS
Settlement
Agreement
On
November 3, 2022, AMMO, Inc. (the “Company”) entered into a
Settlement Agreement (the “Settlement Agreement”) with
Steven F. Urvan and Susan T. Lokey (collectively with each of their
respective affiliates and associates, the “Urvan
Group”).
Pursuant
to the Settlement Agreement, the Urvan Group has agreed to withdraw
its notice of stockholder nomination of its seven director
candidates (the “Urvan Candidates”) and its demand to
inspect books and records, pursuant to Section 220 of the General
Corporation Law of the State of Delaware, and the Company agreed to
immediately increase the size of the Board from seven to nine
directors and appoint Christos Tsentas and Wayne Walker (each, a
“New Director” and the New Directors together with Mr.
Urvan, the “Urvan Group Directors”) to the Board to serve as
directors with terms expiring at the 2022 annual meeting of
stockholders (the “2022 Annual Meeting”). The Company will
include the Urvan Group Directors in its director candidates slate
for the 2022 Annual Meeting and any subsequent annual meeting of
stockholders of the Company occurring prior to the Termination Date
(as defined below). The Company has agreed to not increase the size
of the Board above nine directors prior to the Termination Date
unless the increase is approved by at least seven directors. Mr.
Wagenhals will continue to serve as a director and Chairman of the
Board.
Pursuant to the Settlement Agreement, the Company will suspend the
previously announced separation of Company into Action Outdoor
Sports, Inc. and Outdoor Online, Inc., pending the further
evaluation of strategic options by the Board.
The foregoing summary of the Settlement Agreement does not purport
to be complete and is subject to, and qualified in its entirety, by
reference to the full text of the Settlement Agreement, a copy of
which was previously filed as Exhibit 10.1 in the Form 8-K filed
with the SEC on November 7,2022, and incorporated herein by
reference.
Common
Stock Issuances
Subsequent
to the September 30, 2022, the Company issued 25,000 shares
for employees as compensation for a total value of $87,500 or
$3.50 per share.
Additionally, 150,000 shares were issued pursuant
the exercise of warrants for a total value of $1,500.
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS.
Management’s
Discussion and Analysis of Financial Condition and Results of
Operations is provided to assist the reader in understanding the
results of operations, financial condition, and liquidity through
the eyes of our management team. This section should be read in
conjunction with other sections of this Quarterly Report,
specifically, our Consolidated Financial Statements and
Supplementary Data.
FORWARD-LOOKING
STATEMENTS
This
document contains certain “forward-looking statements”. All
statements other than statements of historical fact are
“forward-looking statements” for purposes of federal and state
securities laws, including, but not limited to, any projections of
earnings, revenue or other financial items; any statements of the
plans, strategies, goals and objectives of management for future
operations; any statements concerning proposed new products and
services or developments thereof; any statements regarding future
economic conditions or performance; any statements or belief; and
any statements of assumptions underlying any of the
foregoing.
Forward
looking statements may include the words “may,” “could,”
“estimate,” “intend,” “continue,” “believe,” “expect,” or
“anticipate,” or other similar words, or the negative thereof.
These forward-looking statements present our estimates and
assumptions only as of the date of this report. Accordingly,
readers are cautioned not to place undue reliance on
forward-looking statements, which speak only as of the dates on
which they are made. We do not undertake to update forward-looking
statements to reflect the impact of circumstances or events that
arise after the dates they are made. You should, however, consult
further disclosures and risk factors we included in the section
titled Risk Factors contained herein.
In
our filings with the Securities and Exchange Commission, references
to “AMMO, Inc.”, “AMMO”, “the Company”, “we,” “us,” “our” and
similar terms refer to AMMO, Inc., a Delaware corporate, and its
wholly owned consolidated subsidiaries.
Overview
Our
vision is to modernize the ammunition industry by bringing new
technologies to market. We intend to do that through acquisition
and application of intellectual property that is unique to the
industry and through investing in manufacturing equipment and
processes that enable us to compete globally.
Our
innovative line of match grade armor piercing (“AP”), hard armor
piercing incendiary (“HAPI”) tactical and ballistically matched
(“BMMPR”) rounds are the centerpiece of the Company’s strategy to
address the unique needs of the armed forces community. This
ammunition was designed around a match grade portfolio of
projectiles, that include a solid copper boat tail and armor
piercing configuration. The distinction between these rounds and
other sold, is that the manufacturing process was engineered to
ensure extremely tight tolerances between each projectile
manufactured, ensuring for the end user that the ballistic
trajectory remains consistent between rounds without regard to the
actual configuration or round fired. The Company has aligned its
manufacturing operations to support the large caliber demand from
military personnel, such as the 7.62x39, .300NM, .338 Lapua, 12.7
mm and .50 caliber BMG configurations. On February 2, 2021, we
announced that we restarted our improved .50 caliber manufacturing
line to address increased market demand and fulfill current
orders.
Through
JMC, we offer ammunition casings for pistol ammunition through
large rifle ammunition. Jagemann Munitions Components is backed by
decades of manufacturing experience that allows the production of
high-quality pistol brass and rifle brass components. Borne from
the automotive industry and refined over time to deliver durable
and consistent sporting components, Jagemann Munition Components™,
has become one of the largest brass manufacturers in the country,
with the capacity to produce more than 750 million pieces of brass
each year with the ability to scale to 1 billion rounds on an
annual basis. Proud of its American-made components and
capabilities, the Company now has complete control over the
manufacturing process. This results in a number of advantages when
it comes to the brass that leaves our state-of-the-art
facility.
On
April 30, 2021, we acquired Gemini and nine of its subsidiaries,
all of which are related to Gemini’s ownership of the GunBroker.com
business.
GunBroker.com
is a large online marketplace dedicated to firearms, hunting,
shooting and related products. Third-party sellers list items on
the site and federal and state laws govern the sale of firearms and
other restricted items. Ownership policies and regulations are
followed using licensed firearms dealers as transfer
agents.
The
focus for our 2023 fiscal year is to continue to expand our brand
presence into the markets identified above and to continue to grow
our sales within our targeted markets. We intend to do this through
establishing key strategic relationships, enrolling in government
procurement programs, establishing relationships with leading law
enforcement associations and programs, expanding distributor
channels, and revitalized marketing campaigns.
Results
of Operations
Our
financial results for the three and six months ended September 30,
2022 reflect our newly positioned organization as we transition
into our new manufacturing facility. We believe that we have hired
a strong team of professionals, developed innovative products, and
continue to raise capital sufficient to establish our presence as a
high-quality ammunition provider and marketplace. We continue to
focus on growing our top line revenue, and streamlining our
operations, and as a result, we experienced a 3.4% increase in our
Net Revenues for the six months ended September 30, 2022 compared
with the six months ended September 30, 2021. This was the result
of production capacity increase, as well as a full quarter of
operations for our new marketplace, GunBroker.com, in comparison to
the prior year period.
The
following table presents summarized financial information taken
from our condensed consolidated statements of operations for the
three and six months ended September 30, 2022 compared with the
three and six months ended September 30, 2021:
|
|
For the Three Months Ended |
|
|
For the Six Months Ended |
|
|
|
September 30,
2022 |
|
|
September 30,
2021 |
|
|
September 30,
2022 |
|
|
September 30,
2021 |
|
|
|
(Unaudited) |
|
|
(Unaudited) |
|
|
(Unaudited) |
|
|
(Unaudited) |
|
Net Sales |
|
$ |
48,288,559 |
|
|
$ |
61,002,085 |
|
|
$ |
109,044,585 |
|
|
$ |
105,478,417 |
|
Cost of Revenues |
|
|
35,452,850 |
|
|
|
34,786,017 |
|
|
|
78,073,214 |
|
|
|
60,291,455 |
|
Gross Margin |
|
|
12,835,709 |
|
|
|
26,216,068 |
|
|
|
30,971,371 |
|
|
|
45,186,962 |
|
Sales, General & Administrative
Expenses |
|
|
13,339,222 |
|
|
|
11,987,750 |
|
|
|
26,412,143 |
|
|
|
21,278,130 |
|
Income (loss) from
Operations |
|
|
(503,513 |
) |
|
|
14,228,318 |
|
|
|
4,559,228 |
|
|
|
23,908,832 |
|
Other income (expense) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other expense |
|
|
(92,167 |
) |
|
|
(112,806 |
) |
|
|
(19,156 |
) |
|
|
(256,660 |
) |
Income (loss)
before provision for income taxes |
|
$ |
(595,680 |
) |
|
$ |
14,115,512 |
|
|
$ |
4,540,072 |
|
|
$ |
23,652,172 |
|
Provision for
income taxes |
|
|
207,827 |
|
|
|
- |
|
|
|
2,090,552 |
|
|
|
- |
|
Net Income
(Loss) |
|
$ |
(803,507 |
) |
|
$ |
14,115,512 |
|
|
$ |
2,449,520 |
|
|
$ |
23,652,172 |
|
Non-GAAP
Financial Measures
We
analyze operational and financial data to evaluate our business,
allocate our resources, and assess our performance. In addition to
total net sales, net loss, and other results under accounting
principles generally accepted in the United States (“GAAP”), the
following information includes key operating metrics and non-GAAP
financial measures we use to evaluate our business. We believe
these measures are useful for period-to-period comparisons of the
Company. We have included these non-GAAP financial measures in this
Quarterly Report on Form 10-Q because they are key measures we use
to evaluate our operational performance, produce future strategies
for our operations, and make strategic decisions, including those
relating to operating expenses and the allocation of our resources.
Accordingly, we believe these measures provide useful information
to investors and others in understanding and evaluating our
operating results in the same manner as our management and board of
directors.
Adjusted
EBITDA
|
|
For the Three Months Ended |
|
|
For the Six Months Ended |
|
|
|
30-Sep-22 |
|
|
30-Sep-21 |
|
|
30-Sep-22 |
|
|
30-Sep-21 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of
GAAP net income to Adjusted EBITDA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Income (Loss) |
|
$ |
(803,507 |
) |
|
$ |
14,115,512 |
|
|
$ |
2,449,520 |
|
|
$ |
23,652,172 |
|
Provision for Income Taxes |
|
|
207,827 |
|
|
|
- |
|
|
|
2,090,552 |
|
|
|
- |
|
Depreciation and amortization |
|
|
4,294,845 |
|
|
|
4,667,957 |
|
|
|
8,594,968 |
|
|
|
8,154,748 |
|
Excise Taxes |
|
|
2,435,051 |
|
|
|
3,937,118 |
|
|
|
6,147,392 |
|
|
|
6,334,889 |
|
Interest expense, net |
|
|
97,265 |
|
|
|
112,806 |
|
|
|
217,752 |
|
|
|
278,085 |
|
Employee stock awards |
|
|
1,176,375 |
|
|
|
1,153,625 |
|
|
|
2,351,438 |
|
|
|
1,853,125 |
|
Stock grants |
|
|
43,750 |
|
|
|
65,098 |
|
|
|
91,594 |
|
|
|
132,012 |
|
Other income, net |
|
|
(5,098 |
) |
|
|
- |
|
|
|
(198,596 |
) |
|
|
(21,425 |
) |
Contingent consideration fair
value |
|
|
(23,944 |
) |
|
|
(3,444 |
) |
|
|
(25,246 |
) |
|
|
(60,082 |
) |
Proxy
contention fees |
|
|
741,131 |
|
|
|
- |
|
|
|
741,131 |
|
|
|
- |
|
Adjusted
EBITDA |
|
$ |
8,163,695 |
|
|
$ |
24,048,672 |
|
|
$ |
22,460,505 |
|
|
$ |
40,323,524 |
|
Adjusted
EBITDA is a non-GAAP financial measure that displays our net income
(loss), adjusted to eliminate the effect of certain items as
described below.
We
have excluded the following non-cash expenses from our non-GAAP
financial measures: provision or benefit for income taxes,
depreciation and amortization, share-based or warrant-based
compensation expenses, changes to the contingent consideration fair
value, expenses incurred as a result of a proxy contention. We
believe it is useful to exclude these non-cash expenses because the
amount of such expenses in any specific period may not directly
correlate to the underlying performance of our business
operations.
Adjusted
EBITDA as a non-GAAP financial measure also excludes other cash
interest income and expense, as these items are not components of
our core operations and we
have included adjustment for excise taxes..
Non-GAAP
financial measures have limitations, should be considered as
supplemental in nature and are not meant as a substitute for the
related financial information prepared in accordance with GAAP.
These limitations include the following:
|
● |
Employee
stock awards and stock grants expense has been, and will continue
to be for the foreseeable future, a significant recurring expense
in the Company and an important part of our compensation
strategy; |
|
● |
the
assets being depreciated or amortized may have to be replaced in
the future, and the non-GAAP financial measures do not reflect cash
capital expenditure requirements for such replacements or for new
capital expenditures or other capital commitments; and |
|
● |
non-GAAP
measures do not reflect changes in, or cash requirements for, our
working capital needs |
|
● |
other
companies, including companies in our industry, may calculate the
non-GAAP financial measures differently or not at all, which
reduces their usefulness as comparative measures. |
Because
of these limitations, you should consider the non-GAAP financial
measures alongside other financial performance measures, including
our net loss and our other financial results presented in
accordance with GAAP.
Net
Sales
The
following table shows our net sales by proprietary ammunition
versus standard ammunition for the three and six months ended
September 30, 2022 and 2021. “Proprietary Ammunition” include those
lines of ammunition manufactured by our facilities that are sold
under the brand names: STREAK VISUAL AMMUNITION™ and Stelth. We
define “Standard Ammunition” as non-proprietary ammunition that
directly competes with other brand manufacturers. Our “Standard
Ammunition” is manufactured within our facility and may also
include completed ammunition that has been acquired in the open
market for sale to others. Also included in this category is low
cost target pistol and rifle ammunition, as well as bulk packaged
ammunition manufactured by us using reprocessed brass casings.
Ammunition within this product line typically carries lower gross
margins.
|
|
For the Three Months Ended |
|
|
For the Six Months Ended |
|
|
|
September 30,
2022 |
|
|
September 30,
2021 |
|
|
September 30,
2022 |
|
|
September 30,
2021 |
|
Proprietary Ammunition |
|
$ |
3,351,993 |
|
|
$ |
1,333,347 |
|
|
$ |
6,207,926 |
|
|
$ |
2,443,968 |
|
Standard
Ammunition |
|
|
26,034,976 |
|
|
|
38,875,055 |
|
|
|
64,148,926 |
|
|
|
66,116,214 |
|
Ammunition
Casings |
|
|
4,338,896 |
|
|
|
4,016,467 |
|
|
|
7,620,093 |
|
|
|
7,868,953 |
|
Marketplace Revenue |
|
|
14,562,694 |
|
|
|
16,777,216 |
|
|
|
31,067,640 |
|
|
|
29,049,282 |
|
Total
Sales |
|
$ |
48,288,559 |
|
|
$ |
61,002,085 |
|
|
$ |
109,044,585 |
|
|
$ |
105,478,417 |
|
Sales
for the three and six months ended September 30, 2022 decreased 21%
and increased 3%, respectively, or approximately $12.7 million and
$3.6 million, over the three and six months ended September 30,
2021. The decrease for the three month period was largely the
result of a decrease of $12.8 million in sales in bulk pistol and
rifle ammunition, an increase of $2.0 million of sales of
Proprietary Ammunition, and a decrease of $2.2 million generated
from our marketplace, GunBroker.com. The increase for the six month
period was the result of an increase of approximately $3.8 million
of sales of Proprietary Ammunition, a decrease of $2.0 million of
sales in bulk pistol and rifle ammunition, an increase of
approximately and $0.2 million of sales from our casing operations,
and an increase of approximately $2.0 million of revenue generated
from our marketplace, GunBroker.com, which includes auction
revenue, payment processing revenue, and shipping income.
Management expects the sales growth rate of Proprietary Ammunition
to greatly outpace the sales of our Standard Ammunition.
We
are focused on continuing to grow top line revenue
quarter-over-quarter as we continue to further expand distribution
into commercial markets, introduce new product lines, and continue
to initiate sales to U.S. law enforcement, military, and
international markets.
Through
our acquisition of SWK, the Company has developed and deployed a
new line of tactical armor piercing (AP) and hard armor piercing
incendiary (HAPI) precision ammunition to meet the lethality
requirements of both the US and foreign military customers. This
line was formally launched at SHOT Show in Las Vegas, where our
team demonstrated or presented the capability to more than 15
countries around the world. We continue to demonstrate our AP and
HAPI ammunition to military personnel at scheduled and invite only
events, resulting in increased interest and procurement
discussions. The Company has since developed the ballistic match
(BMMPR) and signature-on-target (SoT) rounds under contract with
the U.S. Government in support of US special operations which have
been publicly announced pursuant to governmental authorization.
Additional work continues in support of the military operations of
the U.S. and its ally military components which is not currently
subject to disclosure.
It is
important to note that, although U.S. law enforcement, military and
international markets represent significant opportunities for our
Company, they also have a long sales cycle. The Company’s sales
team has been effective in establishing sales and distribution
channels, both in the United States and abroad, which are
reasonably anticipated to drive sustained sales opportunity in the
military, law enforcement, and commercial markets.
Sales
outside of the United States require licenses and approval from
either the U.S. Department of Commerce or the U.S. State
Department, which typically takes approximately 30 days to receive.
On June 16, 2022, we renewed our annual registration with the
International Traffic in Arms Regulations (“ITAR”), which remains
valid through the report date. This permits the Company to export
and broker ammunition and other controlled items covered under
ITAR.
Cost
of Revenues
Cost
of Revenues increased by approximately $.7 million and $17.8
million from $34.8 million and $60.3 million to $ 35.5 million and
$78.1 million for the three and six months ended September 30, 2022
compared to the comparable period ended in 2021. This was the
result of a significant increase in net sales as well increases to
non-cash depreciation related to increases in production equipment,
expensing of increased labor, overhead, and raw materials used to
produce finished product during 2022 as compared to
2021.
Gross
Margin
Our
gross margin percentage decreased to 26.6% and 28.4% from 42.9% and
42.8% during the three and six months ended September 30, 2022,
respectively, as compared to the same period in 2021. The decrease
in our gross margin was related to increased costs of raw
materials, labor, and overhead costs.
We
believe as we continue to grow sales through new markets and
expanded distribution that our gross margins will also increase by
efficiencies added through our new production facility scheduled to
come online this fiscal year. Our goal in the next 12 to 24 months
is to continue to improve our gross margins. This will be
accomplished through the following:
|
● |
Increased
product sales, specifically of proprietary lines of ammunition,
like the STREAK VISUAL AMMUNITION™, Stelth and now our tactical
Armor Piercing (AP) and Hard Armor Piercing Incendiary (HAPI)
precision ammunition, all of which carry higher margins as a
percentage of their selling price; |
|
|
|
|
● |
Introduction
of new lines of ammunition that historically carry higher margins
in the consumer and government sectors; |
|
|
|
|
● |
Reduced
component costs through operation of our ammunition segment and
expansion of strategic relationships with component
providers; |
|
|
|
|
● |
Expanded
use of automation equipment that reduces the total labor required
to assemble finished products; |
|
|
|
|
● |
And
better leverage of our fixed costs through expanded production to
support the sales objectives. |
Operating
Expenses
Overall,
for the three and six months ended September 30, 2022, our
operating expenses increased by approximately $1.4 million and $5.1
million over the three and six months ended September 30, 2021 and
increased as a percentage of sales from 19.7% and 20.1% for the
three and six months ended September 30, 2021 to 27.6% and 24.2%
for the three and six months ended September 30, 2022. Our
operating expenses include non-cash depreciation and amortization
expense of approximately $3.2 million and $6.6 million for the
three and six months ended September 30, 2022, respectively. Our
operating expenses consisted of commissions related to our sales
increases, stock compensation expense associated with issuance of
our Common Stock in lieu of cash compensation for employees, board
members, and key consultants for the organization during the
period. Operating expenses for the three and six months ended
September 30, 2022 included noncash expenses of approximately $7.2
million and $13.4 million, respectively. We expect to see
administrative expenditures decrease as a percentage of sales in
the 2023 fiscal year, as we leverage our work force and expand our
sales opportunities.
During
the three months ended September 30, 2022, our selling and
marketing expenses decreased by approximately $0.5 million, while
for the six months ended September 30, 2022 our selling and
marketing expenses increased by approximately $0.3 million, in
comparison to the three and six months ended September 30, 2021.
The increase was primarily related to commission on the increases
in the sale of our products resulting of approximately $2.0 million
for the six months ended September 30, 2022.
Our
corporate general & administrative expenses increased
approximately $1.0 million and $2.9 million in the three and six
months ended September 30, 2022 from the comparable prior period
mainly due to inclusion of the full six months of Gemini expenses
for the six month period ended September 30, 2022, as compared to
partial inclusion during the period ended September 30, 2021, as a
result of the acquisition occurring on April 30, 2021, as well as,
$0.7 million of fees related to our proxy contention in the three
months ended September 30, 2022.
Employee
salaries and related expenses increased approximately $1.3 million
and $1.7 million for the three and six months ended September 30,
2022 compared to the comparable period ended in 2021. The increase
for the six months ended September 30, 2022 when compared to the
prior period, was primary related to an increase in stock
compensation of approximately $0.5 million.
Depreciation
and amortization expenses for the three months ended September 30,
2022 decreased by approximately $0.4 million, and increased for the
6 months ended September 30, 2022 by approximately $0.3
million.
Interest
and Other Expenses
For
the three and six months ended September 30, 2022, interest expense
decreased by approximately $0.1 million and $0.1 million compared
with the comparable three and six months ended September 30, 2021.
The change from the prior periods was mainly due to the repayment
of notes during the three and six months ended September 30,
2022.
Income
Taxes
For
the three and six months ended September 30, 2022, we recorded a
provision for federal and state income taxes of approximately $0.2
million and $2.1 million, respectively. There was no provision for
federal and state income taxes during the three and six months
ended September 30, 2021.
Net
Income
We
ended the three months ended September 30, 2022 with a net loss of
approximately $.8 million compared with a net income of
approximately $14.1 million for the three months ended September
30, 2021. We ended the six months ended September 30, 2022 with a
net income of approximately $2.5 million compared with a net income
of approximately $23.7 million for the six months ended September
30, 2021.
Our
goal is to continue to improve our operating results as we focus on
increasing sales and controlling our operating expenses.
Liquidity
and Capital Resources
As of
September 30, 2022, we had $29,004,539 of cash and cash
equivalents, an increase of $5,723,064 from March 31,
2022.
Working
Capital is summarized and compared as follows:
|
|
September 30, 2022 |
|
|
March 31, 2022 |
|
Current assets |
|
$ |
132,876,446 |
|
|
$ |
129,691,636 |
|
Current
liabilities |
|
|
31,925,735 |
|
|
|
35,823,311 |
|
|
|
$ |
100,950,711 |
|
|
$ |
93,868,325 |
|
Changes
in cash flows are summarized as follows:
Operating Activities
For the six months ended September 30, 2022, net cash provided by
operations totaled approximately $17.7 million. This was primarily
the result of net income of approximately $2.5 million, which was
offset by increases in our inventories of approximately $9.6
million, decreases in deposits of approximately $2.6 million,
decreases in our accounts receivable of approximately $12.5
million, decreases in prepaid expenses of approximately $1.1
million, decreases in our accounts payable of approximately $3.0
million, and decreases of other liabilities of approximately $1.3
million. Non-cash expenses for depreciation and amortization
totaled approximately $8.6 million and non-cash expenses for
employee stock awards totaled $2.4 million.
For
the six months ended September 30, 2021, net cash used in
operations totaled approximately $7.1 million. This was primarily
the result of net income of approximately $23.7 million, which was
offset by increases in our inventories of approximately $19.1
million, increases in deposits of approximately $14.7 million,
increases in our accounts receivable of approximately $14.2
million, decreases in prepaid expenses of approximately $1.6
million, and increases in our accounts payable and accrued
liabilities of $3.9 million and $1.0 million, respectively.
Non-cash expenses for depreciation and amortization totaled
approximately $8.2 million and non-cash expenses for employee stock
awards totaled $1.9 million.
Investing Activities
During
the six months ended September 30, 2022, we used approximately $8.4
million in net cash for investing activities. Net cash used in
investing activities consisted of approximately $8.4 million
related to purchases of production equipment and the construction
of our new manufacturing facility in Manitowoc, WI.
During the six months ended September 30, 2021, we used
approximately $55.7 million in net cash for investing activities.
Net cash used in investing activities consisted of approximately
$50.5 million used in connection with the merger of Gemini, and
approximately $5.2 million related to purchases of production
equipment and the construction of our new manufacturing facility in
Manitowoc, WI.
Financing Activities
During
the six months ended September 30, 2022, net cash used in financing
activities was approximately $2.6 million. This was the net effect
of an approximate $0.8 million reduction in our Inventory Credit
Facility, approximately $1.3 million from insurance premium note
payments, approximately $1.4 million of Preferred Stock dividends
paid, generation of approximately $45.6 million from accounts
receivable factoring, which was offset by payments of approximately
$45.3 million, and proceeds from our Construction Note Payable of
$1.0 million.
During the six months ended September 30, 2021, net cash used in
financing activities was approximately $22.5 million. This was the
net effect of a $50.0 million payment on debt assumed from Gemini,
$35.0 million of proceeds from the sale of our preferred stock net
of approximately $3.2 million of issuance costs, approximately $0.9
million was generated from common stock issued for exercised
warrants, the $4.0 million repayment of a note payable, payments on
insurance premium note of approximately $1.1 million and an
approximate $0.9 million reduction in our Inventory Credit
Facility. Additionally, approximately $50.4 million was generated
from accounts receivable factoring, which was offset by payments of
approximately $49.1 million.
Liquidity
Existing working capital, cash flow from operations, bank
borrowings, and sales of equity and debt securities are expected to
be adequate to fund our operations over the next year. Generally,
we have financed operations to date through the proceeds of stock
sales, bank financings, and related-party notes. These sources have
been adequate to fund our recurring cash expenditures including but
not limited to our working capital requirements, capital
expenditures to expand our operations, debt repayments, and
acquisitions. We intend to continue use the aforementioned sources
of funding for capital expenditures, debt repayments, share
repurchases and any potential acquisitions.
Leases
We
lease four locations that are used for our offices, production, and
warehousing. As of September 30, 2022, we had $3.0 million of fixed
lease payment obligations with $1.0 million payable within the next
12 months. Please refer to Note 8– Leases for additional
information.
Related
Party Note Payable
As of
September 30, 2022, we had an outstanding balance on our Related
Party Note Payable of approximately $0.5 million, which is due
within the next 12 months.
Construction
Note Payable
We
will finance a portion of our new production facility with our
Construction Note Payable. We expect to make $0.8 million in
principal and interest payments within the next 12 months. The
total principal balance of the Construction Note is expected to be
$11.6 million upon completion of the project and will mature on
October 14, 2026.
Off-Balance Sheet Arrangements
As of
September 30, 2022, we did not have any off-balance sheet
arrangements that have or are reasonably likely to have a current
or future material effect on our financial condition, net sales,
expenses, results of operations, liquidity capital expenditures, or
capital resources.
Critical Accounting Policies
The
preparation of financial statements in conformity with GAAP
requires us to make estimates and assumptions that affected the
reported amounts of assets and liabilities and disclosure of
contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenue and expenses during
the reporting period. Actual results could differ from those
estimates. Significant estimates made in preparing the condensed
consolidated financial statements include the valuation of
allowances for doubtful accounts, valuation of deferred tax assets,
inventories, useful lives of assets, goodwill, intangible assets,
and stock-based compensation. A summary of our critical accounting
policies is included in our Annual Report on Form 10-K for the year
ended March 31, 2022, under “Management’s Discussion and Analysis
of Financial Condition and Results of Operations.” There have been
no significant changes to these policies during the three and six
months ended September 30, 2022. For disclosure regarding recent
accounting pronouncements and the anticipated impact they will have
on our operations, please refer to Note 2 to the consolidated
financial statements included in our Annual Report on Form 10-K for
the year ended March 31, 2022.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT
MARKET RISK
We
are a smaller reporting company as defined by Rule 12b-2 of the
Securities Exchange Act of 1934 and are not required to provide the
information under this item.
ITEM 4. CONTROLS AND PROCEDURES
Evaluation
of Disclosure Controls and Procedures
We
maintain disclosure controls and procedures, as defined in Rule
13a-15(e) promulgated under the Securities Exchange Act of 1934
(the “Exchange Act”), that are designed to ensure that information
required to be disclosed by us in the reports that we file or
submit under the Exchange Act is recorded, processed, summarized
and reported within the time periods specified in the Securities
and Exchange Commission’s rules and forms and that such information
is accumulated and communicated to our Chief Executive Officer and
Chief Financial Officer, as appropriate to allow timely decisions
regarding required disclosure. We carried out an evaluation, under
the supervision and with the participation of our Chief Executive
Officer and Chief Financial Officer, of the effectiveness of the
design and operation of our disclosure controls and procedures as
of September 30, 2022. Based on the evaluation of these disclosure
controls and procedures, our Chief Executive Officer and Chief
Financial Officer concluded our disclosure controls and procedures
were not effective. Our controls were ineffective due to the size
of the Company and available resources. There are limited personnel
to assist with the accounting and financial reporting function,
which results in: (i) a lack of segregation of duties and (ii)
controls that may not be adequately designed or operating
effectively. Despite the existence of material weaknesses, the
Company believes the financial information presented herein is
materially correct and fairly presents the financial position and
operating results of the three months ended September 30, 2022, in
accordance with GAAP.
Changes
in internal controls
There
were no changes in our internal control over financial reporting,
as defined in Rule 13a-15(f) promulgated under the Exchange Act,
during the quarterly period from July 1, 2022 to September 30,
2022, that have materially affected, or are reasonably likely to
materially affect, our internal control over financial
reporting.
PART II - OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
We
are involved in or subject to, or may become involved in or subject
to, routine litigation, claims, disputes, proceedings, and
investigations in the ordinary course of business. While the
outcome of lawsuits and other proceedings against us cannot be
predicted with certainty, in the opinion of management,
individually or in the aggregate, no such lawsuits are expected to
have a material effect on our financial position, results of
operations or cash flows. We record accruals for contingencies when
it is probable that a liability will be incurred and the amount of
loss can be reasonably estimated.
Please
reference the Contingencies section of Note 2 of our Financial
Statements for additional disclosure.
ITEM 1A. RISK FACTORS
We
are a smaller reporting company as defined by Rule 12b-2 of the
Securities Exchange Act of 1934 and are not required to provide the
information under this item.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF
PROCEEDS
The
authorized capital of the Company is 200,000,000 shares of Common
Stock with a par value of $0.001 per share and 10,000,000 shares of
Preferred Stock with a $0.001 par value per share.
There
were no unregistered sales of the Company’s equity securities
during the quarter ended September 30, 2022 that were not
previously reported in a Current Report on Form 8-K.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None
ITEM 4. MINE SAFETY DISCLOSURES
Not
applicable
ITEM 5. OTHER INFORMATION
None
ITEM 6. EXHIBITS
101.INS* |
|
Inline
XBRL Instance Document |
101.SCH* |
|
Inline
XBRL Taxonomy Extension Schema Document |
101.CAL* |
|
Inline
XBRL Taxonomy Extension Calculation Linkbase Document |
101.LAB* |
|
Inline
XBRL Taxonomy Extension Labels Linkbase Document |
101.PRE* |
|
Inline
XBRL Taxonomy Extension Presentation Linkbase Document |
101.DEF* |
|
Inline
XBRL Taxonomy Extension Definition Linkbase Document |
104 |
|
Cover
Page Interactive Data File (formatted as Inline XBRL and contained
in Exhibit 101) |
*Filed
Herewith.
**
Furnished Herewith.
SIGNATURES
In
accordance with Section 13 or 15(d) of the Exchange Act of 1934,
the registrant caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
|
AMMO,
INC. |
|
|
|
|
|
/s/
Fred W. Wagenhals |
Dated:
November 14, 2022 |
By: |
Fred
W. Wagenhals, Chief Executive Officer |
|
|
/s/
Robert D. Wiley |
Dated:
November 14, 2022 |
By: |
Robert
D. Wiley, Chief Financial Officer |
AMMO (NASDAQ:POWW)
Historical Stock Chart
From May 2023 to Jun 2023
AMMO (NASDAQ:POWW)
Historical Stock Chart
From Jun 2022 to Jun 2023